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The development of whole-body imaging at single-cell resolution enables 2 
system-level approaches to studying cellular circuits in organisms. Previous clearing 3 
methods focused on homogenizing mismatched refractive indices of individual 4 
tissues, but more work is needed to make an opaque animal transparent. Here we 5 
show that an aminoalcohol, in our previously described chemical-clearing cocktail 6 
CUBIC, decolorized the blood by efficiently eluting the heme chromophore from 7 
hemoglobin. Direct transcardial CUBIC perfusion coupled with a 10-day to 2-week 8 
clearing protocol decolorized and transparentized almost all organs of adult mice as 9 
well as the entire body of infant and adult mice. This CUBIC-perfusion protocol 10 
enables rapid whole-body and whole-organ imaging at single-cell resolution by using 11 
light-sheet fluorescent microscopy. CUBIC is also applicable to 3D pathology, 12 
anatomy, and immunohistochemistry of various organs. These results suggest that 13 
whole-body imaging of colorless tissues at high resolution will contribute to 14 





! Aminoalcohol in the CUBIC cocktail decolorized tissues by eluting heme  3 
! CUBIC is a simple and efficient whole-organ and whole-body clearing 4 
protocol  5 
 6 
! CUBIC enables whole-organ and whole-body imaging with single-cell 7 
resolution  8 
 9 





!  1 
INTRODUCTION 2 
Since the discovery of cells in the organism about 350 years ago (Hooke, 1665), 3 
whole-body imaging of single cells in opaque organisms like mammals, has been a 4 
fundamental challenge in biology and medicine. Imaging intact structures at 5 
single-cell resolution will enable a systems-level elucidation of cellular connectivity 6 
and dynamics. This will improve our understanding of the generation and progression 7 
of diseases with stochastic and proliferative processes such as autoimmune and 8 
malignant neoplastic diseases, because single-cell events in these diseases 9 
eventually affect the health status of the entire organism. However, even the ~30 g 10 
body of an adult mouse comprises more than 30 billion cells, which makes it difficult 11 
to comprehensively identify cellular circuits and quantitatively analyse dynamics. 12 
Conventional histology techniques are laborious and require tissue sectioning, which 13 
are challenging barriers toward rapid three-dimensional (3D) visualization of organ 14 
structures.   15 
By contrast, optical sectioning with light-sheet microscopy in combination with recent 16 
advances in tissue-clearing techniques is a promising route toward visualizing single 17 
cells within a whole organ or whole body context (Dodt et al., 2007; Ertürk et al., 18 
2012; Keller and Dodt, 2012; Susaki et al., 2014; Tomer et al., 2014). The pioneering 19 
work by Werner Spalteholz first introduced the principle of transparent 20 
three-dimensional specimens a century ago (Spalteholz, 1914). Up until now, a 21 
number of tissue-clearing reagents (BABB, THF-DBE, Scale, SeeDB, ClearT) and 22 
protocols (3DISCO, CLARITY, PACT-PARS) have been developed (Becker et al., 23 
2012; Chung et al., 2013; Dodt et al., 2007; Ertürk et al., 2012; Hama et al., 2011; Ke 24 
et al., 2013; Kuwajima et al., 2013; Tomer et al., 2011; Yang et al., 2014). However, 25 
they cleared tissues to different degrees of transparency. In order to observe deep 26 
tissue structures, we aimed for a level of transparency of internal organs (such as 27 
 5 
heart, lung, kidney, liver, pancreas, spleen, stomach, small and large intestines) and 1 
soft tissues (such as muscles) to the extent that 1) chest and abdominal backbones 2 
and the bones of limbs through internal organs and soft tissues from both ventral and 3 
dorsal sides of the body are visible, and 2) individual cells within intact organs and 4 
tissues are resolved by whole-body or whole-organ imaging. We previously 5 
demonstrated that aminoalcohol-based chemical cocktails, termed CUBIC (Clear, 6 
Unobstructed Brain Imaging Cocktails and Computational Analysis), efficiently 7 
transparentized whole brains of adult mice by removing lipids to homogenizing 8 
refractive indices (RIs) without signal loss from fluorescence proteins (Susaki et al., 9 
2014). All previous tissue-clearing methods including ours have mainly focused on 10 
homogenizing RIs, and some of them based on the lipid removal (BABB, 3DISCO, 11 
CLARITY, CUBIC, PACT-PARS) succeeded in the clearing and imaging of adult 12 
whole brain (Becker et al., 2012; Chung et al., 2013; Dodt et al., 2007; Ertürk et al., 13 
2012; Susaki et al., 2014; Yang et al., 2014), which is a relatively lipid rich tissue. 14 
However, when applied to the whole body, thick tissues block photons in the visible 15 
region (400-600 nm) not only because of light-scattering by endogenous materials 16 
with mismatched RIs, but also because of the light-absorbance by endogenous 17 
chromophores, mainly hemoglobin and myoglobin (Faber et al., 2003; Weissleder, 18 
2001). Thus, efficient decolorization of endogenous chromophores inside tissues 19 
(particularly heme, which is one of the most abundant endogenous chromophores) is 20 
needed to clear whole-body tissues. Classical treatment by the peroxide decolorizes 21 
tissues. However, this peroxide treatment causes not only serious damages to outer 22 
tissues (Steinke and Wolff, 2001) but also a significant loss of GFP signal (Alnuami et 23 
al., 2008). Heme tightly binds to hemoglobin, and can be released only in highly 24 
acidic (≤ pH 2) or basic (≥ pH 11) conditions (Kristinsson and Hultin, 2004; Teale, 25 
1959). This highly acidic or basic treatment also results in significant loss of signals 26 
from GFP-related fluorescence proteins (Haupts et al., 1998). Thus, a clearing 27 
method is needed to efficiently elute heme in moderately basic conditions to enable 28 
GFP-related fluorescence proteins to retain their fluorescence properties. 29 
 6 
. 1 
In this study, we demonstrate that CUBIC cocktails, especially aminoalcohols, 2 
decolorized the blood by efficiently eluting the heme chromophore from hemoglobin in 3 
moderately basic conditions. An accelerated clearing protocol with CUBIC perfusion 4 
sufficiently transparentized almost all organs of adult mice as well as the entire bodies 5 
of infant and adult mice, and enabled rapid whole-body and whole-organ imaging with 6 
single-cell resolution. We used CUBIC to diagnose the pathology of Langerhans islets 7 
in the diabetic pancreas, as well as to anatomically annotate various organ structures 8 
in 3D. We also applied CUBIC to 3D immunohistochemistry of various organs. These 9 
results suggest that whole-body imaging with single-cell resolution achieved by 10 




Aminoalcohols in CUBIC cocktails decolorized the blood by efficiently eluting 15 
heme chromophore 16 
To achieve whole-body imaging with single-cell resolution, it is important to decolorize 17 
endogenous chromophores such as heme. When we immersed various organs 18 
directly (i.e. without perfusion) to paraformaldehyde (PFA) and subjected them to 19 
ScaleCUBIC-1 (in this study, we termed “CUBIC-1” for its simplicity), we found that 20 
the color of the solvent immediately turned a dark green. This unexpected finding 21 
allowed us to hypothesize that CUBIC-1 reagent could solubilize and elute 22 
endogenous heme from blood-infused tissues. To test this hypothesis, we first 23 
investigated whether CUBIC reagents can directly decolorize blood. When a blood 24 
suspension was fixed by PFA and subjected to the CUBIC-1 reagent, we confirmed 25 
that the color of the mixture immediately turned a dark green. The pellet after 26 
centrifugation was then washed three times with CUBIC-1 reagent, resulting in 27 
 7 
transparent pellet and olive-green supernatant, respectively (Figure 1A). On the 1 
other hand, the pellet and the supernatant from PBS-treated blood suspension 2 
remained dark red and colorless, respectively. To determine the decolorizing 3 
chemical in CUBIC-1, the PFA-fixed blood was washed with 4 
N,N,N',N'-tetrakis(2-hydroxypropyl)ethylenediamine (termed here as “aminoalcohol 5 
#10”) (Susaki et al., 2014), urea, or Triton X-100, respectively. As a result, 6 
aminoalcohol #10 alone, but not other reagents, is sufficient to decolorize the blood 7 
(Figure 1A). We also found that PFA-fixed blood could not be decolorized by glycerol, 8 
a mixture of urea and Triton X-100, or modified ScaleA2 (the mixture of glycerol, urea, 9 
and Triton X-100) (Figure 1B), suggesting that aminoalcohol #10 in CUBIC-1 reagent 10 
is the active reagent in blood clearing. We also note that the decolorizing capability of 11 
aminoalcohol #10 is not solely dependent on its high pH because PFA-fixed blood 12 
was not efficiently decolorized by highly basic solution (0.01 M NaOH, initial pH = 12). 13 
Therefore, the blood decolorizing nature of aminoalcohol #10 in a moderately basic 14 
condition originates from its chemical property. 15 
We next investigated what kind of olive-green molecule was eluted from the 16 
blood into the supernatant. Erythrocytes purified from mouse blood were mixed with 17 
PBS, highly basic solution (0.1 M NaOH, initial pH = 13), aminoalcohol #10 or 18 
CUBIC-1 reagent, respectively, and incubated at 37°C overnight. Then, the visible 19 
spectra of these samples were recorded by spectrometer (Figure 1C). We noticed 20 
that visible spectrum from the PBS-treated erythrocyte suspension is quite different 21 
from those of erythrocyte suspension treated by NaOH, aminoalcohol #10 and 22 
CUBIC-1 reagent, and speculated that heme molecules would be released from 23 
hemoglobin in NaOH, aminoalcohol #10 or CUBIC-1-treated samples. To directly test 24 
this hypothesis, we recorded the visible spectra from purified hemin (free heme 25 
chromophore released from hemoglobin), purified biliverdin (which is a product of 26 
heme catabolism), iron(II) chloride, erythrocytes, and supernatant of PFA-fixed blood 27 
treated by aminoalcohol #10 (Figure 1D) or CUBIC-1 reagent (Figure S1A). The 28 
 8 
normalized spectra of the erythrocyte and supernatant overlapped almost completely 1 
with hemin solutions in #10 or CUBIC-1, which suggests that heme is released from 2 
hemoglobin in erythrocytes when treated by aminoalcohol #10 or the CUBIC-1 3 
reagent. 4 
Aminoalcohol #10 in the CUBIC-1 reagent can solubilize and elute the heme 5 
in the blood more efficiently than highly basic solution (0.01 M NaOH, initial pH = 12) 6 
(Figure 1A). What kind of chemical property in aminoalcohol #10 enables heme 7 
elution at moderate pH? As shown in Figure 1A, we noticed that the pH variations 8 
were relatively small between the original liquid and the subsequent supernatant for 9 
samples treated by aminoalcohol #10 and CUBIC-1 reagent when compared with 10 
highly basic solution (0.01 M NaOH, initial pH = 12). These results indicate that 11 
aminoalcohol #10 has buffering capacity at moderately basic conditions. To directly 12 
test the buffering capacity of these reagents, we prepared aminoalcohol #10 and 13 
CUBIC-1 reagent, together with urea, Triton X-100, and glycerol in a basic solution 14 
containing 0.01 M NaOH, and then titrated with 1 M HCl (Figure S1B). Aminoalcohol 15 
#10 and CUBIC-1 reagent have buffering capacity in pH 9-11 whereas other reagents 16 
did not. If buffering capacity in basic pH is critical for the decolorizing capability, we 17 
predicted that a basic solution containing 0.01 M NaOH, which usually elutes heme 18 
from hemoglobin, will lose its decolorizing capability at a higher concentration of 19 
erythrocytes because the higher concentration of cells will shift the pH from basic to 20 
neutral. To test this prediction, we prepared a mixture of erythrocytes and these 21 
chemicals at different ratios (Figure 1E). Although urea and Triton X-100 in basic 22 
solution moderately promoted heme release at high chemical ratios, these were less 23 
effective at lower concentrations. On the other hand, aminoalcohol #10 and CUBIC-1 24 
reagent promoted heme release even at high erythrocyte ratios. As shown in Figure 25 
1C, the absorbance ratio between 600 nm and 575 nm can be used as a quantitative 26 
index for the efficiency of heme release. OD600/OD575 values of samples from 27 
Figure 1E were therefore plotted against erythrocyte/chemical ratio (Figure S1C; 28 
 9 
and because the absorbance saturated at erythrocyte/chemical ratio = 0.20 in Figure 1 
1E, the OD600/OD575 values at this ratio were not collected in Figure S1C). These 2 
results quantitatively confirmed that aminoalcohol #10 in the CUBIC-1 reagent can 3 
efficiently promote heme release regardless of the erythrocyte/chemical ratio, and 4 
work as a decolorizing buffer at moderate basic pH. 5 
Since previous studies reported that heme can be released only in highly 6 
basic (≥ pH 11) or acidic (≤ pH 2) conditions (Kristinsson and Hultin, 2004; Teale, 7 
1959), the remaining question is whether the decolorizing capability of aminoalcohol 8 
#10 in the CUBIC-1 reagent occurs only in highly basic conditions (pH > 11), or can 9 
occur in less basic conditions (pH < 11), in which GFP-related fluorescence proteins 10 
emit stronger fluorescence signal (Haupts et al., 1998). Thus, we evaluated the pH 11 
dependence on the efficiency of heme release for aminoalcohol #10, CUBIC-1 12 
reagent and non-buffered basic solution, respectively (Figure 1F). In non-buffered 13 
basic solution, heme was efficiently released from hemoglobin, but only at pH > 11, 14 
as previously reported. On the other hand, aminoalcohol #10 efficiently eluted heme 15 
even in moderately basic conditions around pH 10, which is within the optimal pH 16 
range for fluorescence signal intensity of GFP-related fluorescence proteins (Haupts 17 
et al., 1998). CUBIC-1 reagent further promoted heme release even around pH 9, 18 
which might be attributed to a combinatorial effect with urea and/or Triton X-100. 19 
These results suggested that aminoalcohol #10 in CUBIC-1 reagent expanded the pH 20 
window for efficient heme release. 21 
To clarify the chemical properties of aminoalcohol #10 associated with its 22 
decolorizing capability, we investigated erythrocyte with a series of aminoalcohol 23 
derivatives (Figure S1E), which include primary amine (#8, #15, and Tris), secondary 24 
amine (#4), tertiary amine (#9, #10, #16, and #17) (Susaki et al., 2014) and amine 25 
bearing carboxylic acid groups (DHEG and EDTA) (Figure S1D). We evaluated the 26 
decolorizing efficiency by OD600/OD575 values described as above. The 27 
decolorizing efficiency of primary amines is lower than those of secondary and tertiary 28 
 10 
amines (See also Figure 1F). Carboxylic groups also suppressed the decolorizing 1 
capability. These results revealed the chemical properties (i.e. higher amines without 2 
carboxylic groups) associated with efficient decolorizing and might reflect the affinity 3 
of these chemicals to the heme chromophore. Overall, aminoalcohol in CUBIC 4 
reagents critically contributed to blood decolorization, which is assisted by its 5 
chemical capacities to buffer pH in moderately basic conditions and to expand the pH 6 
window for efficient heme release. 7 
 8 
CUBIC is a simple and efficient whole-organ and whole-body clearing protocol 9 
A number of tissue-clearing methods (including BABB, THF-DBE, Scale, SeeDB, 10 
ClearT, 3DISCO, CLARITY, CUBIC, and PACT-PARS) have been intensively 11 
developed. Because a simple and versatile protocol will facilitate a high-throughput 12 
approach to understanding cellular circuits in organisms, we mainly focused on the 13 
development of an immersion-only tissue-clearing protocol. Organic solvent-based 14 
clearing media such as BABB, THF-DBE decrease signals from fluorescent proteins 15 
with short duration (Ertürk et al., 2012; Hama et al., 2011). In addition, benzylalcohol 16 
and THF inherently generates potentially explosive peroxide and this also quenches 17 
the fluorescence signals of fluorescent proteins (Alnuami et al., 2008). Therefore, 18 
peroxides in benzylalcohol and THF have to be removed by specific apparatus before 19 
use. Although organic solvent based clearing medium remains to be attractive in the 20 
clearing performance, these experimental drawbacks compelled us to focus on 21 
water-based clearing reagents. We thus evaluated the clearing performance of 22 
representative Scale, SeeDB, and CUBIC protocols in various organs. Each protocol 23 
was based on the experimental conditions of the original papers as shown in Figure 24 
2A except for a daily exchange of the clearing medium. We measured the temporal 25 
development of average transmittance of different organs (brain, heart, lung, kidney, 26 
and liver) with each protocol (Figure S2A) and obtained transmittance curves of 27 
these organs around the visible region after 10 days (Figure S2B). The CUBIC 28 
 11 
protocol was superior to other methods in both clearing kinetics and plateau 1 
performance in transmittance for all organs studied. We confirmed that the CUBIC 2 
protocol enhanced the transmittance of organs in the 480-680 nm range, as expected 3 
from the decolorizing capability of CUBIC reagents. Bright-field images of different 4 
organs (brain, heart, lung, kidney, liver, pancreas, spleen, muscle, stomach and 5 
intestine, and skin) after 10 days also demonstrated that all organs treated with 6 
CUBIC reagents resulted in the most transparentized and decolorized images 7 
(Figure 2A). 8 
Based on the blood decolorizing capability of the CUBIC-1 reagent, 9 
transcardial perfusion of this reagent (and hence the blood decolorizaion through 10 
blood vessels) will enhance whole-organ and whole-body clearing. We thus 11 
developed a CUBIC perfusion (CB-Perfusion) protocol to achieve whole-organ and 12 
whole-body clearing. In the original CUBIC protocol, tissues were conventionally fixed 13 
by transcardial perfusion of 4% PFA (25 - 50 ml), and immersed in 4% PFA at 4˚C 14 
overnight as a post-fixation. In the advanced CB-Perfusion protocol, tissues in the 15 
entire body were fixed by prolonged transcardial perfusion of 4% PFA (150 ml), and 16 
then cleared by subsequent transcardial perfusion of 1/2 diluted CUBIC-1 reagents 17 
(20 ml). Each organ was then extracted and further cleared by CUBIC reagents. The 18 
CB-Perfusion protocol accelerated the clearing kinetics and further enhanced the 19 
plateau performance in transmittance when compared with the original CUBIC 20 
protocol (Figures S2A and S2B). In a bright-field imaging comparison of all organs, 21 
the CB-perfused organs were the clearest (Figure 2A). These results indicate 22 
successful development of the whole-organ clearing protocol, which finishes within 10 23 
days. 24 
We next attempted whole-body clearing of infant [postnatal day 1 (P1) and 25 
P6] and adult mice (19-week-old) by using this CB-Perfusion protocol. After 26 
transcardial perfusion of 4% PFA and 1/2 diluted CUBIC-1 reagent and subsequent 27 
detachment of skin, the entire body was cleared by the CUBIC-1 reagent. We noticed 28 
 12 
that the clearing medium (CUBIC-1 reagent) immediately turned a dark green color 1 
probably due to decolorization of endogenous chromophores (mainly heme). To 2 
facilitate the whole-body clearing, clearing medium were refreshed daily for two 3 
weeks. The clearing medium gradually became less colored, and after two weeks the 4 
apparent transparency of the whole body became saturated. Whole-body samples 5 
can be then stored in CUBIC-1 reagent, and even shaken in 37°C over months 6 
because the high pH of CUBIC-1 reagents prevents proliferation of microorganisms. 7 
Bright-field images of infant mice (P1 and P6) demonstrated that CB-Perfusion 8 
protocol transparentized and decolorized P1 and P6 infant mice (Figure 2B). We 9 
confirmed the visualization of chest and abdominal backbones as well as bones of 10 
limbs through internal organs and soft tissues from both ventral and dorsal sides of 11 
the body (Figure 2B). 12 
Bright-field images of adult mice (19-week-old) demonstrated that 13 
CB-Perfusion protocol also markedly transparentized and decolorized adult mice 14 
(Figures 2B and S2C). Since the abdominal organs of adult mouse (including liver, 15 
pancreas, spleen, stomach, and small and large intestines) were sufficiently 16 
transparentized and decolorized, the backbones (the lumbar and sacrum vertebrae) 17 
and pelvis were easily visualized even in the ventral-to-dorsal (V-D) image of adult 18 
mice (Figure 2B). Similarly, the chest organs of adult mouse (including lung, heart, 19 
aorta, pulmonary artery and bronchi) were also highly transparentized and 20 
decolorized. Hence, the backbones (the cervical and thoracic vertebrae) and entire 21 
rib cages were easily visualized even in the ventral-to-dorsal (V-D) image of adult 22 
mice (Figure 2B). Furthermore, the muscles of limbs in adult mouse were markedly 23 
transparentized and decolorized. Therefore, the bones of forelimbs (including scapula, 24 
humerus, radius and ulna) and hindlimbs (including femur, tibia and fibula), and 25 
caudal vertebrae were clearly visualized in either V-D or the dorsal-to-ventral (D-V) 26 
images of adult mice (Figures 2B and S2C). 27 
 28 
 13 
CUBIC is applicable to whole-body imaging of infant and adult mice with 1 
single-cell resolution 2 
The high transparency of CB-perfused samples prompted us to perform light-sheet 3 
fluorescence microscopy (LSFM). As previously described, the CUBIC protocol is 4 
compatible with whole-brain nuclear counterstaining (Susaki et al., 2014). We thus 5 
applied nuclear counterstaining by propidium iodide (PI) to whole-body samples and 6 
imaged PI-stained CAG-EGFP transgenic (Tg) (Okabe et al., 1997) P1 mouse 7 
transparentized and decolorized by the CB-Perfusion protocol. Whole-body images 8 
were obtained from two opposite directions (D-V and V-D) (Figure 3A). Both images 9 
were sufficiently clear even at 4-5 mm depth. Nuclear-staining with PI tends to 10 
highlight non-muscular organs and solid tissues, whereas CAG-EGFP signals were 11 
more intense in the muscular organs such as heart and subcutaneous tissue. We 12 
noted that PI fluorescence signal was enhanced where it binds not only with DNA in 13 
the nucleus of internal organs and soft tissues but also in bone tissues. Although 14 
light-sheet illumination was shaded to some extent by bone-rich structures such as 15 
paws, fluorescence signal from shaded regions was still detectable. According to the 16 
whole-body images, organ transparency was not diminished through the whole-body 17 
clearing procedure compared to clearing of individual organs separately. Magnified 18 
images from the same sample were also obtained to visualize internal structures of 19 
head, chest, abdominal and pelvic organs as well as limbs (Figures 3B, S3A, and 20 
S4). These images were then deconvolved by AutoQuant X3 software (we denoted 21 
the deconvolved images as prefix “DCV-” in the figures). For example, the granule 22 
duct in the submaxillary gland, coronary vessels in the heart, bronchiole in the lung, 23 
gastric walls in the stomach, vascular structures in the liver, renal cortex and medulla 24 
in the kidney, villus in the intestine, and penis and testis in the scrotum were clearly 25 
identified in each z stack image (Figure S4). Surprisingly, detailed structures in 26 
hippocampus and cerebellum were visible through the skull, central canal inside the 27 
spinal cords were seen through vertebrae, and internal structures of tibia in the leg 28 
 14 
were also visualized (Figures 3B and S4). We note that the magnified images of 1 
these organs resolved to single-cell levels (Figure 3C, top panel). We also performed 2 
whole-body imaging of PI-stained CAG-EGFP Tg P6 mouse transparentized and 3 
decolorized by the CB-Perfusion protocol. Since the P6 mouse was too large to be 4 
captured in a single view, we obtained whole-body images from three views (head, 5 
chest and abdomen, Figure S3C). The quality of whole-body images of P6 mice were 6 
almost comparable to those of P1 mice, and visualized the internal structures of head, 7 
chest, abdominal and pelvic organs as well as limbs. 8 
We next performed whole-body imaging of PI-stained CAG-EGFP Tg adult 9 
mice (8-week-old) transparentized and decolorized by the CB-Perfusion protocol. 10 
Adult mice bodies, could not fit into existing LSFMs so we dissected the adult body 11 
into four parts (chest organs, abdominal organs, forelimbs and hindlimbs), and then 12 
obtained their images (Figures 3D and S3B). Adult mouse tissues exhibited much 13 
higher contrast between PI and EGFP signals than those of infant mice. For example, 14 
EGFP signals were much higher in heart, pancreas, stomach and muscles probably 15 
because EGFP expression from CAG promoter in these organs was elevated. In 16 
z-stack images of chest organs, ventricle structures in the heart and bronchiole in the 17 
lung can be clearly visualized (Figure 3D). In z-stack images of abdominal organs, 18 
vascular structure in the liver, cortex and medulla in the kidney, muscularis externa in 19 
the stomach, and villus in the intestine were also visualized (Figure 3D). Tibia and 20 
fibula as well as fiber orientation of gastrocnemius and muscles in the hindlimb were 21 
also clearly visualized (Figure 3D). We note that the images of these adult organs 22 
also achieved single-cell resolution (Figure 3C, bottom panel). These results 23 
demonstrated that CUBIC is applicable to the imaging of the internal structures of 24 
entire body regions (chest and abdominal organs, forelimb and hindlimb) with 25 
single-cell resolution. 26 
 27 
 15 
CUBIC is applicable to whole-organ imaging with single-cell resolution 1 
For rapid whole-organ imaging, we used a knock-in (KI) mouse strain expressing 2 
three tandem repeats of mKate2 with a nuclear localization signal, under control of 3 
the CAG promoter (Niwa et al., 1991) from the 3’-UTR of β-actin gene locus (Tanaka 4 
et al., 2012). We used mKate2 because of its signal intensity, photostability and rapid 5 
protein maturation (Chudakov et al., 2010; Shcherbo et al., 2009), as well as its 6 
resistance to fluorescence quenching by CUBIC reagents as previously described 7 
(Susaki et al., 2014). We then performed whole-organ imaging of various 8 
CB-perfused organs including heart, lung, kidney, liver, pancreas, spleen, muscle, 9 
stomach, and intestine from this β-actin-nuc-3×mKate2 KI mouse (8-week-old), and 10 
counter-stained with SYTO 16, a cell-permeable green-fluorescent nucleic acid stain. 11 
The resulting 3D-reconstituted image of each organ in this mKate2 KI mouse as well 12 
as its horizontal, coronal, and sagittal sections enabled the visualization of spatial 13 
gene expression patterns (from the CAG promoter at β-actin 3’-UTR) and 14 
examination of detailed internal structures (Figures 4A-4D and S4A-S4F). For 15 
example, 3D-reconstitution images of the heart successfully visualized not only 16 
lumens of atria and ventricle but also internal papillary muscle, coronary vascular 17 
structures, and even valve structures (Figure 4A). In the heart, SYTO 16 signals 18 
highlighted epicardium, papillary muscle, and right atrium whereas mKate2 signal 19 
was higher in coronary vessels. The expression level of mKate2 is dependent on the 20 
cell type in each tissue because mKate2 is expressed under the control of CAG 21 
promoter in ROSA26 locus, and therefore distribution of the mKate2 fluorescent 22 
signals reflected the expression of the knocked-in expression cassette. On the other 23 
hand, SYTO 16 indiscriminately stained all cell nuclei in the tissue. Thus, distribution 24 
of the SYTO 16 fluorescent signals was attributed to the cell density in each tissue. In 25 
lungs, the networks of trachea, bronchi, and bronchiole in both lobes were clearly 26 
identified (Figure 4B). Pleura, trachea, and probably pulmonary alveoli in lobes were 27 
also identified. In the kidney, 3D-reconstitution images easily distinguished between 28 
 16 
renal cortex, medulla and pelvis (Figure 4C). In the liver, two kinds of vascular 1 
structures were identified as thicker vessels, which would indicate the hepatic artery, 2 
and thinner vessels, which would indicate the portal vein (Figure 4D). Langerhans 3 
islets and pancreatic ducts were identified in the pancreas (Figure S5A). Splenic 4 
white pulp and red pulp were identified in the spleen (Figure S5B). Orientations of 5 
muscle fibers and blood vessels were observed in the muscle (Figure S5C). Corpus 6 
glands were significantly highlighted, and pylorus and cardia were clearly observed in 7 
the stomach (Figure S5D). Mesentery and villi were seen in the intestine (Figure 8 
S5E). We also obtained 3D-reconstitution images of brain as well as kidney and 9 
muscle, which are contralateral to those in Figures 4C and S5C from the identical 10 
mouse body (Figure S5F). 11 
The successful whole-organ imaging using mKate2 led us to test other 12 
fluorescence proteins, including EGFP, and YFP. We performed similar whole-organ 13 
imaging of each organ from three strains of CB-perfused adult mice: CAG-EGFP Tg 14 
(Figures S6A), an EGFP-fused histone-2B-expressing strain (R26-H2B-EGFP 15 
[CDB0239K]; Figure S6B) (Abe et al., 2011), and a Thy1-YFP-H Tg strain (Figure 16 
S6C) (Feng et al., 2000), respectively. PI was used as nuclear-staining for 17 
whole-organ imaging of these strains. When we captured the section images of each 18 
organ from CAG-EGFP Tg (Figure S6A) and β-actin-nuc-3×mKate2 KI mice 19 
(Figures 4 and S5), the spatial distribution of fluorescence proteins (EGFP and 20 
nuc-3×mKate2) was markedly different. This is because EGFP was localized in the 21 
nucleus and cytosol whereas mKate2 was localized only in the nucleus. Therefore, 22 
EGFP signals were useful for the visualization of the orientation of muscular fibers in 23 
heart and muscle, whereas mKate2 signals could highlight the vascular and duct 24 
structures in heart, kidney, pancreas, and spleen. In addition, expression levels of 25 
these fluorescence proteins varied in each organ. For example, EGFP signals were 26 
more intense in the heart and the pancreas whereas mKate2 signals were elevated in 27 
the brain, the kidney, and the pancreas. Similarly, we could obtain 3D-reconstitution 28 
 17 
images of whole-organs from R26-H2B-EGFP and the neuronal marker Thy1-YFP-H 1 
(Figures S6B and S6C). These results demonstrate that CUBIC protocol enables 2 
whole-organ imaging with various fluorescence proteins (mKate2, EGFP and YFP), 3 
and that whole-organ imaging with single-cell resolution can extract 3D single-cell 4 
information of internal anatomical structures in different organs. 5 
In addition to imaging internal organs and muscles, we collected skin and 6 
ears from pelage-removed CAG-EGFP Tg mouse, and subjected them to CUBIC 7 
reagents with nuclear-counterstain PI. We then performed whole-organ imaging of 8 
these tissues (Figure 4E). EGFP signals highlighted epidermis, muscle layer under 9 
hypodermis, and residual pelage, whereas PI signal intensity was relatively higher in 10 
hair matrix cells. Adipocyte-rich hypodermis was not stained by either signal, but 11 
dermal structures and fluorescence protein expression were well preserved during 12 
the CUBIC procedure. Taken together, these results demonstrate that CUBIC 13 
enables whole-organ imaging with single-cell resolution of almost all organs by using 14 
various fluorescence proteins. 15 
 16 
CUBIC is applicable to 3D pathology of Langerhans islets in the diabetic 17 
pancreas 18 
One attractive application of whole-body and whole-organ imaging with single-cell 19 
resolution is 3D pathology of organs. To test this potential, we investigated the spatial 20 
distribution of Langerhans islets (LIs) in diabetic and normal pancreases by using the 21 
CB-Perfusion protocol. As a model, we first focused on diabetic pancreases because 22 
BABB-based analysis combined with optical projection tomography (OPT) has 23 
already been applied (Alanentalo et al., 2007). However, BABB clearing with 24 
OPT-based imaging has several limitations such as fluorescence quenching of 25 
endogenous fluorescence proteins and relatively low spatial resolution, both of which 26 
can be addressed by whole-organ clearing by CUBIC reagents combined with 27 
 18 
whole-organ LSFM imaging. Streptozotocin (STZ) is a well-known cytotoxic agent for 1 
pancreatic β-cells, which disrupts the ability of β-cells to secrete insulin and stabilize 2 
blood sugar levels (King, 2012). High-dose STZ injection destroys β-cells, which are 3 
major constituents of LIs, and induce type I diabetes mellitus (King, 2012). LIs 4 
contract because of β-cell destruction after the onset of diabetes. We therefore 5 
performed comprehensive and statistical analysis of diabetic LIs in the 6 
whole-pancreas of adult mice. We administered a relatively high-dose STZ (200 7 
mg/kg) intraperitoneally to WT C57BL/6N mice (8-week-old). After four days, blood 8 
sugar levels of 36% of the mice were elevated over 300 mg/dl, which is a 9 
commonly-used criterion for the diagnosis of diabetes (Table S1). We then dissected 10 
and transparentized pancreases from saline-treated control mice (n = 3) and acute 11 
type I diabetic mice (n = 3, whose blood sugar levels were over 400 mg/dl as shown 12 
in Table S1) by the CB-Perfusion protocol with PI staining. In order to reliably identify 13 
all LIs in the pancreas, we acquired 6-10 sets of the magnified z-stack images to 14 
cover the entire pancreas. LIs were identified as dense clusters of PI-stained cellular 15 
nuclei in the magnified images. These images also enabled us to morphologically 16 
distinguish the characteristic clusters (LIs) from the characteristic tracts (pancreatic 17 
ducts) (Figure 5A). We identified all LIs by visual annotation of all z-stack planes in 18 
all sets of magnified images of a pancreas. The extracted LIs were then 19 
3D-reconstituted by the surface analysis in the Imaris software. For example, yellow 20 
(in the indicated z-stack plane) and blue objects (outside the indicated z-stack plane) 21 
indicate LIs whereas green objects indicate pancreatic ducts (Figure 5A). The image 22 
analysis also provided a spatial distribution of LIs in the pancreas. For example, 23 
larger LIs tend to be localized along pancreatic ducts. By using the extracted LIs data, 24 
we can compare the total number of LIs between diabetic and healthy mice. As 25 
expected, the average number of LIs was significantly reduced by the onset of 26 
diabetes (Figure 5B, left panel, p = 0.005). The differences of average LI volume 27 
between diabetic and healthy mice were also marginally significant (Figure 5B, 28 
center panel, p = 0.09), which is consistent with the observed reduction in the 29 
 19 
existence probability of larger LIs in diabetic mice (> 1.0×107 µm3, Figure 5B, right 1 
panel). These data indicate that larger LIs are more susceptible to β-cell impairment 2 
induced by STZ administration. Overall, these results indicate that CUBIC enables 3D 3 
pathology of a diabetic pancreas. 4 
 5 
CUBIC is applicable to 3D anatomy of various organs 6 
The successful 3D pathology of diabetic pancreases prompted us to generalize this to 7 
3D anatomy of various organs, which may provide a versatile platform for elucidation 8 
of cellular mechanisms underlying the physiology and pathology of observed 9 
anatomical structures. As a test case, we analysed whole-heart images from mKate2 10 
KI mouse. We noted that mKate2 signals are intenser in the surface of the tracts, 11 
which can be morphologically annotated as coronary vessels (Figure 6A). We 12 
extracted, by using the surface analysis in the Imaris software, high intensity signals 13 
in the heart and excluded the surfaces of smaller volume size, resulting in 3D images 14 
of coronary vessels covering the entire heart (Figure 6A and Movie S1). Internal 15 
structures such as tendinous cords and valves could be also visualized (Figure S7A). 16 
We also analysed whole-lung images from the same mKate2 KI mouse. We noted 17 
that mKate2 signals in respiratory tract fall to undetectable levels, and thus we can 18 
extract low intensity signals in the lungs, resulting in a bronchial tree covering the 19 
entire lung (Figure 6B and Movies S2 and S3). Interestingly, the 3D-reconstituted 20 
image of the tree includes main stem bronchus, bronchi, bronchioles, and even 21 
alveoli structures. We next analyzed whole-kidney images from the same mKate2 KI 22 
mouse. Renal cortex, medulla and pelvis were clearly distinguished and annotated 23 
with characteristic signal patterns of SYTO16 and mKate2 (Figure 6C and Movie S4). 24 
We further analyzed whole-liver images from the same mKate2 KI mouse (Figure 6D 25 
and Movie S5). We extracted two vessel structures inside the image, which were 26 
characterized by high and low SYTO 16 signals, and thus identified as hepatic 27 
 20 
arteries and portal veins, respectively. Finally, we extended similar anatomical 1 
analysis to whole-body images of PI-stained CAG-EGFP Tg P1 mouse (Figure 3). 2 
Each organ inside the chest and upper abdomen were clearly visualized (Figure S8A 3 
and Movie S6) with their inside structures, such as a bronchial tree in the lung 4 
(Figure S8B), vascular structures in the liver (Figure S8C), villi in the intestine 5 
(Figure S8D), and spatial relations of esophagus and esophageal gland (Figure 6 
S8E). These results suggest that CUBIC enables 3D anatomy of various organs even 7 
in whole-body images, which will provide a versatile platform for system-level 8 
elucidation of cellular circuits underlying the physiology and pathology of various 9 
organs of interest. 10 
 11 
CUBIC is applicable to 3D immunohistochemistry of various organs 12 
Another challenge for establishing whole-organ imaging is the development of 3D 13 
immunohistochemistry (3D-IHC). In our previous work, we have demonstrated that 14 
CUBIC was applicable to the 3D-IHC using large blocks of brain tissue (Susaki et al., 15 
2014). According to the protocol, we performed 3D-IHC of nuclear-stained 16 
whole-organ samples (Figure 7A). Organ samples with CB-Perfusion were subjected 17 
to CUBIC-1 treatment, followed by 3D-IHC with antibodies to two proteins expressed 18 
in the organs. We used α-smooth muscle actin (α-SMA) antibody to label the heart, 19 
stomach, and intestine and pan-cytokeratin antibody to the lung. After 20 
immunostaining, organ samples were treated with CUBIC-2 for several hours to 1 day, 21 
and the resulting samples were observed with LSFM. The immunostained signals 22 
were detected over 1mm depth and visualized as 3D reconstituted images (Figure 7). 23 
In the heart, the immunofluorescence signal for α-SMA antibody clearly highlighted 24 
vascular structures (Figure 7B). Epithelial cells in the lung were visualized by 25 
immunostaining with the antibody to pan-cytokeratin (Figure 7C). Previously reported 26 
staining pattern of pan-cytokeratin was recapitulated by CUBIC-based 3D-IHC (Xiang 27 
 21 
et al., 2007). α-SMA antibody also visualized smooth muscular cells in the stomach 1 
and intestine (Figures 7D and 7E). The CUBIC protocol is thus applicable to the 2 
3D-IHC of various organs. 3 
 4 
DISCUSSION 5 
Aminoalcohols in CUBIC enable decolorization of blood 6 
Almost all animals are not transparent because their body is composed of 7 
RI-mismatched materials as well as light-absorbing pigments. Although a number of 8 
tissue-clearing methods (BABB, THF-DBE, Scale, SeeDB, ClearT) and protocols 9 
(3DISCO, CLARITY, PACT-PARS) have been developed, the importance of 10 
tissue-decolorization was not seriously taken into account because these methods 11 
were mainly optimized for pigment-less brains and hence focused on the adjustment 12 
of mismatched RIs (Becker et al., 2012; Chung et al., 2013; Dodt et al., 2007; Ertürk 13 
et al., 2012; Hama et al., 2011; Ke et al., 2013; Kuwajima et al., 2013; Yang et al., 14 
2014). However, when applied to whole body, thick tissues may block photons in the 15 
visible region due to the absorbance by endogenous pigments. Animals genetically 16 
lacking endogenous pigments have see-through bodies such as the medaka, in 17 
which superficial organs can be visualized across body surfaces (Ohshima et al., 18 
2013; Wakamatsu et al., 2001). Therefore, to visualize detailed structures in deeper 19 
organs by single-photon excitation microscopy, we have to overcome the 20 
light-absorbance by heme, which is one of the most abundant chromophores in the 21 
body (Faber et al., 2003; Weissleder, 2001), in addition to light-scattering by 22 
mismatched RIs. In the previous study, we demonstrated that aminoalcohols in 23 
CUBIC cocktails significantly enhanced whole-brain clearing via homogenizing 24 
mismatched RIs (Susaki et al., 2014). In this study, we discovered another 25 
unexpected chemical nature of aminoalcohols - tissue-decolorization. 26 
 22 
The reddish color of tissue originates mainly from the coordination of oxygen 1 
and histidine with heme in hemoglobin. Q bands (around 500-700 nm) of heme in 2 
erythrocytes treated with aminoalcohol #10 or CUBIC-1 reagent were considerably 3 
changed from those of hemoglobin-bound form (Figure 1C). Those were also 4 
different from Q bands of alkaline-denatured free form of heme. These results imply 5 
that the aminoalcohols could be tightly bound to heme porphyrin instead of oxygen 6 
and histidine in hemoglobin, which may facilitate heme release and explain the 7 
unexpected expansion of the effective pH window for heme release. We also found 8 
that secondary and tertiary amines with higher coordination capability than primary 9 
amines significantly decolorized the blood whereas related amines with a (charged) 10 
carboxyl group (DHEG and EDTA) exhibited less decolorizing capability (Figure 11 
S1D). We also note that the protonated (and hence charged) form of the 12 
aminoalcohol #10 (below its buffering pH ~10) decreased its decolorizing capability 13 
(Figure 1F). Since a heme molecule possesses an electron-deficient iron center and 14 
two negatively charged carboxyl groups, we speculated that uncharged aminoalcohol 15 
#10, which possesses highly coordinating tertiary amino groups, might have suitable 16 
chemical properties to efficiently coordinate to heme for blood decolorization. 17 
In addition to this chemical property, the buffering capability of aminoalcohol 18 
#10 in moderately basic conditions should also contribute to the decolorizing 19 
performance. For example, hemoglobin has been usually quantified in basic Triton 20 
X-100 (pH > 13) because Triton X-100 could bind to heme in highly alkaline 21 
conditions (Wolf et al., 1984). However, the decolorization by basic Triton X-100 22 
without buffering capability was not effective due to its variable pH (Figure 1E). 23 
Therefore, the buffering capability of aminoalcohol #10 will assist the release of heme 24 
either by Triton X-100 or aminoalcohol #10 itself. If aminoalcohol #10 did not have a 25 
buffering capability, the stable decolorizing capability may not be exerted (Figure 1F), 26 
as shown for Triton X-100 (Figure 1E). Importantly, the buffering capability of 27 
aminoalcohol #10 is exerted in moderately basic conditions, which is the optimal pH 28 
 23 
range for the fluorescence signal from GFP-related fluorescence proteins (Haupts et 1 
al., 1998). In fact, treatment of individual organs by CUBIC reagents led to much 2 
higher transmittance in the visible region than that of organs treated by other reagents 3 
(Figure S2B) while CUBIC reagents could preserve the fluorescence signal from 4 
various kinds of GFP-related fluorescence proteins (Figure S6). Taken together, two 5 
chemical properties (a heme-coordinating capability and a buffering capability in 6 
moderately basic conditions) contribute to decolorize the tissue and simultaneously 7 
preserve fluorescence signal from GFP-related fluorescence proteins. 8 
 9 
CUBIC enables whole-body clearing and whole-body imaging with single-cell 10 
resolution 11 
In this study, we demonstrated that the CB-Perfusion protocol, which enabled both 12 
tissue-decolorization and adjustment of mismatched RIs, achieved the visualization of 13 
chest and abdominal backbones through internal organs as well as bones of limbs 14 
through soft tissues from both ventral and dorsal sides of the adult and infant mice 15 
(Figure 2B). We also demonstrated that the CB-Perfusion protocol achieved 16 
whole-body (Figure 3) and whole-organ (Figure 4) imaging with single-cell resolution. 17 
We note that CUBIC is also compatible with other protocols. For example, we 18 
previously demonstrated that CUBIC reagents are applicable to clear 19 
acrylamide-gel-embedded samples prepared according to the CLARITY protocol 20 
(Susaki et al., 2014). Therefore, we expect that another CLARITY-inspired PARS 21 
protocol can be a useful fixation method for the endogenous molecules before CUBIC 22 
treatment. Since the PARS method is based on the intracardiac circulation of 23 
detergents (Yang et al., 2014), which is analogous to the CB-Perfusion protocol, 24 
additional circulation of decolorizing medium (CUBIC cocktails) might increase 25 
transparency in the PARS method. 26 
 24 
There are still some fundamental technical challenges remaining in both 1 
whole-body clearing and whole-body imaging. Although, in this study CUBIC cocktails 2 
enabled the transparency of internal organs and soft tissues for the infant and adult 3 
mice body by tissue-decolorization, these clearing reagents are not effective to bones. 4 
Conventionally, decalcification is rendered by the continuous immersion of acids 5 
(such as formic acids), or chelating agents (such as EDTA) (Mack et al., 2014). 6 
Therefore, the combination of effective chelating solution with CUBIC cocktails might 7 
provide further decalcification properties for the current chemical cocktail. 8 
Alternatively, larger chemical screening by using a chemical screening platform for 9 
tissue-clearing reagents (Susaki et al., 2014) would afford a series of alternative 10 
candidates for tissue- and/or bone-clearing reagents. The chemical profiling of such 11 
compounds will reveal the potent chemical nature for tissue- and bone-clearing 12 
medium, which will eventually provide more potent clearing reagents with less 13 
drawbacks. In whole-body imaging, further optimization of LSFM setup is also 14 
required to seamlessly capture whole-body images of adult mice. Since the movable 15 
range of the stage was limited in the currently existing LSFM setup, the largest field of 16 
view corresponded to a P1 mouse. An entire adult mouse is much thicker, wider and 17 
longer than the body of an infant mouse. Thus, extension of focus depth in the 18 
illuminated light-sheet, expansion of the movable range of the stage, and seamless 19 
tiling of the reconstituted images should be improved in future LSFM setups. 20 
 21 
CUBIC is applicable to 3D pathology, anatomy, and immunohistochemistry 22 
Whole-body and whole-organ imaging with single-cell resolution will play a 23 
fundamental role in achieving 3D pathology and anatomy, which will aid in 24 
systems-level elucidation of cellular mechanisms underlying abnormal and normal 25 
body states. In this study, we applied CUBIC-based whole-body clearing and 26 
LSFM-based whole-organ/whole-body imaging to achieve 3D pathology, anatomy, 27 
 25 
and immunohistochemistry. As a model-case study, we analyzed entire pancreases 1 
in diabetic and normal mice, and performed 3D pathology, which revealed the volume 2 
distribution of LIs between diabetic and healthy mice. As expected, the total number 3 
and volume distribution of LIs were significantly different between normal and diabetic 4 
mice (Figure 5). We also note that larger LIs tend to be localized along pancreatic 5 
ducts, and are more susceptible to β-cell impairment induced by STZ administration.  6 
The application of whole-body and whole-organ imaging techniques is not 7 
limited to the pancreas, but can be extended to other organs. In this study, we 8 
demonstrated that 3D anatomy is feasible for other medically important structures 9 
from whole-organ (Figure 6) or whole-body images (Figure S8) such as coronary 10 
vessels in the heart, the bronchial tree in the lungs, glomeruli distributed through the 11 
cortex and the medullary rays in the kidney, artery and vein networks of the liver, and 12 
villi in the intestine. Although such medically important structures are annotated 13 
manually in this study, automated or semi-automated extraction of medically 14 
important anatomical structures will facilitate 3D pathology and anatomy in future. As 15 
a pilot study, we attempted and succeeded in semi-automated extraction of medically 16 
important anatomical structures in abdominal and chest organs such as LIs in the 17 
pancreas (Figure 5C) and the coronary vessels in the heart (Figure S7B). We also 18 
note that CUBIC application is not limited to transgenic mice with fluorescence 19 
reporter (Figure 7). Since 3D-IHC is compatible with CUBIC, this whole-organ and 20 
whole-body clearing technique can be widely applied to various mice without 21 
fluorescence reporter. When combined with informatics as well as 22 
immunohistochemistry, CUBIC will thus contribute to the systems-level elucidation of 23 
cellular mechanisms underlying the generation and progression of diseases 24 
especially with stochastic and proliferative processes such as autoimmune diseases. 25 
New research fields such as organism-level systems biology based on whole-body 26 




EXPERIMENTAL PROCEDURES 2 
Details are also supplied in EXTENDED EXPERIMENTAL PROCEDURES. 3 
Decolorization of the blood by aminoalcohols in CUBIC cocktails 4 
PFA-fixed blood was thoroughly mixed with each chemical and resultant pellet and 5 
supernatant were imaged by bright-field microscopy. For taking visible spectra data, 6 
erythrocytes were mixed with each chemical and incubated at 37°C overnight. The 7 
mixtures and supernatant were diluted 10-fold with each chemical. The visible spectra 8 
of samples were recorded by UV/Vis spectrometer (JASCO, V-550, Japan). In the 9 
decoloring capacity test, the mixtures of erythrocytes and each chemical with different 10 
mixing ratios (erythrocyte/chemical = 0.01 to 0.20) were incubated at 37°C overnight. 11 
Bright-field images of these samples were captured. In the pH dependency of heme 12 
release, erythrocytes were mixed with each chemical, and incubated at 37°C for 1h. 13 
The OD575 and OD600 values of the mixtures were measured with the PowerWave 14 
XS and the attached operation software (Bio-Tek). 15 
 16 
Mice 17 
The β-actin-mKate2 knock-in mouse (β-actin-CAG-nuc-3×mKate2) strain was 18 
previously established in our laboratory. We also used the R26-H2B-EGFP KI 19 
(CDB0238K) (Abe et al., 2011), the Thy1-YFP-H Tg (Feng et al., 2000), and the 20 
C57BL/6-Tg (CAG-EGFP) (Okabe et al., 1997), the BALB/cAJcl-nu/nu, and wild-type 21 
C57BL/6N mouse strains. We fed DietGel Recovery (LSG Corporation, 72-06-5022, 22 
Japan) to mice for imaging the intestine. Diabetes was induced in male C57BL/6N 23 
mice at 8 weeks by a single intraperitoneal administration of saline or 10 mg/ml 24 
streptozotocin (total 200 mg/kg, Wako Pure Chemical Industries, Ltd., 197-15153, 25 
 27 
Japan) at day 0. Blood glucose values were measured by a blood glucose monitor 1 
(GLUCOCARD G Black; ARKRAY, Inc., Japan) after fasting for 6 hrs at day 0 and 4. 2 
Mice with blood glucose levels over 300 mg/dl (n = 5) at day 4 and 3 
saline-administered mice (n = 4) were used for clearing with CUBIC perfusion and PI 4 
staining. All experimental procedures and housing conditions were approved by the 5 
Animal Care and the Use Committee of Graduate School of Medicine, the University 6 
of Tokyo or by the Animal Care and Use Committee of the RIKEN Kobe Institute and 7 
all of the animals were cared for and treated humanely in accordance with the 8 
Institutional Guidelines for Experiments using animals. 9 
 10 
The CUBIC protocol and other clearing methods 11 
Two CUBIC reagents were prepared as previously reported (Susaki et al., 2014). For 12 
preparation of CUBIC-treated (non-perfused) samples, the fixed organs were 13 
immersed in CUBIC-1 reagent for 5 days and further immersed in CUBIC-2 reagent. 14 
To make CUBIC-1 reagent penetrate throughout the whole body, we also performed 15 
the CB-perfusion protocol. The anesthetized adult mouse was perfused with 10 ml of 16 
10 U/ml of heparin in PBS, 150 ml of 4% (w/v) PFA in PBS, 20 ml of PBS (to wash out 17 
PFA), and 20 ml of 50% (v/v) CUBIC-1 reagent (1 : 1 mixture of water : CUBIC-1) in 18 
this order via left ventricle of the heart. (The protocol was slightly modified for infant 19 
mice.) The resulted whole animal or excised organs were continuously immersed in 20 
CUBIC-1 reagent for 5 days to several weeks. Organs were further immersed in 21 
CUBIC-2 reagent. All organs except skin were collected from C57BL/6N mice; skin 22 
was collected from BALBc-nu/nu mice to save plucking hairs before clearing. These 23 
samples were stained with nucleic acid stains PI (life technologies, P21493) or SYTO 24 
16 (life technologies, S7578), when indicated. We also performed SeeDB standard 25 
protocol (Ke et al., 2013) and Sca/eA2 and Sca/eB4 protocol (Hama et al., 2011). 26 
Light transmittance was measured with an integrating sphere (Spectral Haze Meter 27 
 28 
SH 7000, Nippon Denshoku Industries Co., Ltd., Japan).  1 
 2 
Microscopy and Image analysis 3 
Whole-body and organ fluorescence images were acquired with light-sheet 4 
fluorescence microscopy (LSFM) (Ultramicroscope, LaVision BioTec, Germany) as 5 
reported previously (Dodt et al., 2007; Susaki et al., 2014). All raw image data were 6 
collected in a lossless 16-bit TIFF format. 3D-rendered images were visualized, 7 
captured and analyzed with Imaris software (version 7.6.4 and 7.7.1, Bitplane). Blind 8 
3D deconvolution for a set of our LSFM Z-stack images was performed with software 9 
AutoQuant X3 (Media Cybernetics). Anatomical structures and LI quantification were 10 
performed with surface analysis of Imaris software. Automated detections of 11 
anatomical structure were performed with Fiji (Schindelin et al., 2012) and using a 12 
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Figure 1. Aminoalcohols in CUBIC cocktails decolorized the blood by efficiently 2 
eluting heme chromophore. 3 
(A) Decolorizing of the PFA-fixed blood by the previously published CUBIC-1 cocktail 4 
(“CUBIC-1”) and its constituents. Numbering of aminoalcohol #10 was derived from 5 
the previous chemical screening. Bright-field images of pellet and supernatant from 6 
fixed blood samples washed with PBS, CUBIC-1 reagent, 25 wt% aminoalcohol #10, 7 
25 wt% urea, 15 wt% Triton X-100, or 0.01 M NaOH, respectively. pH of the original 8 
liquid and supernatant are shown at the bottom. (B) Decolorizing PFA-fixed blood by 9 
CUBIC-related chemicals. Transmittance images of pellet and supernatant from 10 
PFA-fixed blood samples washed with PBS, CUBIC-1 reagent (“CUBIC-1”), a mixture 11 
of 25 wt% urea and 15 wt% Triton X-100 (“Urea+ Triton X”), 25 wt% glycerol 12 
(“Glycerol”), or a mixture of 25 wt% urea, 25 wt% glycerol and 15 wt% Triton X-100 13 
(“Modified ScaleA2”), respectively. pH of the original liquid and supernatant are 14 
shown at the bottom. (C) Visible spectra of a chemically-treated 0.1% mouse 15 
erythrocyte suspension. Erythrocytes were mixed with PBS (gray), 0.1 M NaOH 16 
(black), aminoalcohol #10 (magenta), or CUBIC-1 reagent (red), and incubated at 17 
37°C overnight. Inset: magnification of the Q-band region. (D) Normalized visible 18 
spectra of 0.1% mouse erythrocyte (black), 1/10 diluted supernatant from A (red), 10 19 
µM hemin (blue), 10 µM biliverdin (orange), and 100 µM iron(II) chloride (green), in 25 20 
wt% aminoalcohol #10. (E) Aminoalcohol #10 in CUBIC reagents facilitates the 21 
release of heme independent of the mixing ratio with erythrocytes. Bright-field images 22 
of the 1% to 20% erythrocyte suspension mixed with CUBIC-1 reagent (pH = 11.7), 23 
25 wt% aminoalcohol #10 (pH = 11.4), 25 wt% basic glycerol (pH = 11.6), 25 wt% 24 
basic urea (pH = 12.7), 15 wt% basic Triton X-100 (pH =11.8), and 0.01 M NaOH (pH 25 
= 12.0). Indicated value in each well corresponds to pH. (F) Aminoalcohol #10 in 26 
CUBIC reagents significantly expands the pH range of heme release. 1% erythrocyte 27 
suspension including 1-100 mM NaOH (black diamond, n = 3), aminoalcohol #10 (pH 28 
 37 
= 9.4-11.0, magenta square, n = 3), CUBIC-1 (pH = 9.2-11.1, red circle, n = 3), and 25 1 
wt% tris(hydroxymethyl)aminomethane (pH = 10.6-11.8, green triangle, n = 3)  2 
incubated at 37°C overnight. Visible spectra of these samples were recorded. Since 3 
OD600/575 correlates with the efficiency of heme release, OD600/575 of these 4 
samples is plotted against pH. Data represent the average ± SD. See also Figure S1. 5 
 38 
 1 
Figure 2. CUBIC provides a simple and efficient whole-organ and whole-body 2 
clearing protocol. 3 
(A) (Top panel) whole-organ clearing protocol in ten days. (Middle panels) 4 
transmission images of whole organs (brain, heart, lung, kidney, liver, pancreas, 5 
spleen, and muscle) from adult C57BL/6N. In the CB-Perfusion protocol, deeply 6 
anesthetized mice were sacrificed and transcardially perfused with PBS, 4% 7 
PFA/PBS (w/v), and 1/2 diluted CUBIC-1 reagent. The excised organs were further 8 
cleared by CUBIC-1 reagent without post-fixation in 4% PFA/PBS. (Bottom left 9 
panels) bright-field images of whole stomach and intestine from C57BL/6N treated 10 
with the CUBIC, CB-Perfusion protocol, SeeDB, or PBS using 10-day clearing 11 
protocol (Scale-treated stomach and intestine were usually fragile and torn during the 12 
procedure due to proliferation of microorganisms, thus were impossible to take 13 
comparison data). (Bottom right panels) Bright-field images of skin from 14 
BALB/c-nu/nu treated with CUBIC reagents and PBS using the 10-day clearing 15 
protocol. (B) Whole-body clearing protocol in two weeks. Bright-field images (ventral 16 
and dorsal view) of whole body (C57BL/6N P1, P6, and adult mice) stocked in PBS 17 
after fixation or subjected to the CB-Perfusion protocol. 8-week-old mouse for the 18 
PBS sample and 19-week-old mouse for the cleared sample are shown. See also 19 




Figure 3. CUBIC is applicable to whole-body imaging of infant and adult mice with 2 
single-cell resolution. 3 
(A) 3D-reconstituted and X-Y plane (indicated with Z position), lower-resolution 4 
whole-body images of PI-stained CAG-EGFP Tg P1 mouse. Images were acquired 5 
with light-sheet fluorescence microscopy (LSFM) from the ventral-to-dorsal (V-D) and 6 
dorsal-to-ventral (D-V) directions, respectively. Z-stack: 20-µm step, with 4.0 seconds 7 
× two illuminations for EGFP and with 0.1 seconds × two illuminations for PI. Zoom of 8 
the microscope: 0.63×. (B) 3D-reconstituted and X-Y plane body images of PI-stained 9 
CAG-EGFP Tg P1 mouse. Head (D-V), chest organs (V-D), abdominal and pelvic 10 
organs (V-D and D-V) are shown. All images were deconvolved with AutoQuant X3 11 
software. Z-stack: 20-µm step, with 4.0 seconds × two illuminations for EGFP and 12 
with 0.1 to 0.15 seconds × two illuminations for PI. Zoom of the microscope: 2.0× 13 
except 2.5× for chest V-D images. Prefix “DCV-” indicates the deconvolved image. 14 
(C) Magnified images in B (Chest, Z = 2500) and D (Chest, Z = 3000) indicating these 15 
images taken with single-cell resolution. Each dot is PI signals of single cell nucleus. 16 
(D) 3D-reconstituted and X-Y plane body images of the PI-stained CAG-EGFP Tg 17 
adult mouse (8-week-old). Chest organs (V-D), upper abdominal organs (V-D), lower 18 
abdominal organs (D-V), forelimb, and hindlimb are shown. Z-stack: 20-µm step, with 19 
0.4 to 2.0 seconds × two illuminations for EGFP and with 0.1 to 0.2 seconds × two 20 
illuminations for PI. Zoom of the microscope: 0.8× except 1.25× for chest V-D images. 21 
Enlarged parts in C are indicated as white box in B and D. Prefix “DCV-” indicates the 22 




Figure 4. CUBIC is applicable to whole-organ imaging with single-cell resolution. 2 
The reconstituted 3D and section images of a heart (A), lung (B), kidney (C) and liver 3 
(D) from nuclear-stained β-actin-nuc-3×mKate2 KI mouse (8-week-old), and skin and 4 
ear (E) from CAG-EGFP Tg mouse (10-week-old) were acquired with LSFM. Raw 5 
X-Y section images, and reconstituted Y-Z and X-Z section images are at the 6 
indicated positions. Prefix “DCV-” indicates the deconvolved image. In A – D, 7 
enlarged images indicated by white box on Z plane images are shown, indicating 8 
these images are taken at single-cell resolution. Each dot is nuclear-localized mKate2 9 
signals from single cell nuclei. (A) Heart images. Z-stack: 20-µm step × 346 planes, 10 
with 0.05 seconds × two illuminations for SYTO 16 and with 0.5 seconds × two 11 
illuminations for mKate2. Zoom of the microscope: 2.0×. (B) Lung images. Z-stack: 12 
20-µm step × 306 planes, with 0.05 seconds × two illuminations for SYTO 16 and with 13 
1.0 seconds × two illuminations for mKate2. Zoom of the microscope: 1.0×. (C) 14 
Kidney images. Z-stack: 20-µm step × 256 planes, with 0.05 seconds × two 15 
illuminations for SYTO 16 and with 0.5 seconds × two illuminations for mKate2. Zoom 16 
of the microscope: 1.6×. (D) Liver images. Z-stack: 20-µm step × 266 planes, with 17 
0.05 seconds × two illuminations for SYTO 16 and with 0.5 seconds × two 18 
illuminations for mKate2. Zoom of the microscope: 1.0×. (E) Skin and ear images. 19 
Z-stack: 20-µm step, with 0.2 to 0.5 seconds × two illuminations for EGFP and with 20 
0.1 seconds × two illuminations for PI. Zoom of the microscope: 1.6× for ear, 2.0× for 21 




Figure 5. CUBIC is applicable to the 3D pathology of Langerhans islets in the diabetic 2 
pancreas. 3 
(A) The procedures for image analysis of LIs in pancreases. First, LIs in each X-Y 4 
plane image were manually identified. Seven LIs (white circles) were identified in the 5 
center-top panel. Then, these LIs were visualized in 3D image with surface analysis 6 
on the Imaris software. In the right-top panel, the seven LIs (yellow) are in the plane. 7 
Four other LIs (blue) are not in the same plane. The pancreatic duct (green) is also 8 
indicated. The spatial distribution of LIs (blue) as well as a pancreatic duct (green) is 9 
displayed in the left-bottom and center-bottom panels. Finally, LI counting and volume 10 
analysis was conducted on the Imaris software, in the right-bottom panel. (B) 11 
Statistical analysis of LIs in the whole pancreas from control mice (n = 3) and 12 
diabetes mice (n = 3). Data represent the average ± SE. The average number of LIs 13 
was significantly reduced by the onset of diabetes (left panel, p = 0.005). The 14 
differences of average LI volume between diabetic and healthy mice were also 15 
marginally significant (center panel, p = 0.09), which is consistent with the observed 16 
reduction in the existence probability of larger LIs in diabetic mice (> 1.0×107 µm3, 17 
right panel). (C) Computational, semi-automated identification of LIs. Position 1 18 
image of #1 mouse was used. (left and center panels) raw and processed image with 19 
extracted islets (green circles) at plane 80. (right panel) reconstituted 3D image with 20 




Figure 6. CUBIC is applicable to the 3D anatomy of various organs. 2 
Extraction of internal structures was performed with surface analysis of Imaris 3 
software. The reconstituted 3D images of the heart (A), lung (B), kidney (C), and liver 4 
(D) from the SYTO 16-stained β-actin-nuc-3×mKate2 KI mouse (8-week-old) in 5 
Figure 4 were used. After surface extraction by the software, each structure was 6 
manually curated and extra surface signals were eliminated. (A) Structural 7 
identification of coronary vessels and ventricles in the heart. Contiguous mKate2 8 
signals with high or low intensity within the heart were extracted as coronary vessels 9 
(left two panels) or ventricles (right two panels). RAu, right auricle; RAt, right atrium; 10 
RV, right ventricle; LA, left atrium; LV, left ventricle; PA, pulmonary artery; PV, left 11 
ventricle. (B) Structural identification of the bronchial tree (light blue) and peripheral 12 
alveoli (green) in the lung. Contiguous mKate2 signals with moderate intensity within 13 
or the edge of the lung were extracted as the bronchial tree or alveoli, distinguished 14 
by their values of surface area. (C) Structural identification of renal cortex, medulla 15 
and pelvis in the kidney. High intensity signals in SYTO 16 channel, and high or low 16 
intensity signals of mKate2 channel were extracted as the cortex, medulla or pelvis, 17 
respectively. (D) Structural identification of vessels in the liver. Two types of vascular 18 
structures (with or without high-concentrated nuclei signals around the vessel) were 19 
distinguished. Contiguous SYTO 16 signals with low or moderate intensity was 20 
extracted as the portal vein (blue) or wall of the hepatic artery (red), respectively. In 21 
mKate2 channel, similar contiguous signals with low intensity were also extracted and 22 




Figure 7. CUBIC is applicable to the 3D immunohistochemistry (3D-IHC) of various 2 
organs. 3 
(A) CUBIC protocol for 3D immunohistochemistry (3D-IHC) of CB-Perfused various 4 
organs. The reconstituted 3D and section images of a SYTO 16- or PI-stained heart 5 
(B), lung (C), stomach (D) and Intestine (E) from C57BL/6N mouse (11-week-old) 6 
immunostained with Cy3-conjugated anti-α-SMA for heart, stomach, and intestine or 7 
FITC-conjugated anti-pan cytokeratin for lung were acquired with LSFM. Magnified 8 
3D images and raw X-Y section images are at the indicated positions. (B) Heart 9 
images. Z-stack: 10-µm step × 501 planes (whole image) or × 201 planes (magnified 10 
image), with 0.1 seconds × two illuminations or 0.1 seconds × single illumination for 11 
SYTO 16 and with 2.0 seconds × two illuminations or 3.0 seconds × single 12 
illumination for Cy3, respectively. Zoom of the microscope: 2.5× or 6.3×. (C) Lung 13 
images. Z-stack: 10-µm step × 511 planes (whole image) or × 101 planes (magnified 14 
image), with 0.1 seconds × two illuminations or 0.2 seconds × two illuminations for PI 15 
and with 2.0 seconds × two illuminations or 3.0 seconds × two illuminations for FITC, 16 
respectively. Zoom of the microscope: 1.6× or 6.3×. (D) Stomach images. Z-stack: 17 
10-µm step × 381 planes (whole image) or × 167 planes (magnified image), with 0.1 18 
seconds × two illuminations or 0.1 seconds × single illumination for SYTO 16 and with 19 
1.0 seconds × two illuminations or 1.0 seconds × single illumination for Cy3, 20 
respectively. Zoom of the microscope: 2.0× or 6.3×. (E) Intestine images. Z-stack: 21 
10-µm step × 371 planes (whole image) or × 101 planes (magnified image), with 0.1 22 
seconds × two illuminations or 0.1 seconds × single illumination for SYTO-16 and with 23 
2.0 seconds × two illuminations or 3.0 seconds × single illumination for Cy3, 24 




EXTENDED EXPERIMENTAL PROCEDURES 1 
Decolorization of the Blood by Aminoalcohols in CUBIC Cocktails 2 
PFA-fixed blood was prepared by equivalent mixing of murine blood and 8% 3 
PFA-PBS, and incubated at 37°C overnight. Erythrocytes were purified by 4 
centrifugation of incoagulable blood including 1 mg/ml EDTA at 3000 rpm for 30 5 
min, supernatant wasting, and followed by three-times washing with 1 ml PBS 6 
and centrifugation at 3000 rpm for 30 min. Both blood samples were stored at 7 
4°C. In the decoloring experiments of PFA-fixed blood (Figures 1A and 1B), 8 
PFA-fixed blood (100 µl) was thoroughly mixed with each chemical (400 µl of 9 
PBS, CUBIC-1 reagent, 25 wt% 10 
N,N,N',N'-tetrakis(2-hydroxypropyl)ethylenediamine (aminoalcohol #10 (Susaki 11 
et al., 2014)), 25 wt% urea, 15 wt% Triton X-100, 0.01 M NaOH, the mixture of 12 
25 wt% urea and 15 wt% Triton X-100, 25 wt% glycerol, or the mixture of 25 wt% 13 
urea, 25 wt% glycerol, and 15 wt% Triton X-100), and then immediately 14 
centrifuged at 15000 rpm for 5 min. Supernatant was collected and pellet was 15 
washed with each chemical (500 µl) three times (we noted that since mixing 16 
efficiency is critical for the clearing performance in the washing step, the mixture 17 
should be not only mixed by a vortex mixer, but also vigorously stirred by the 18 
small spatula). The pellet was suspended in each chemical (500 µl), and 19 
transferred in the dish. The collected supernatant (500 µl) was also transferred in 20 
the dish. Bright-field images of these samples were captured. In the visible 21 
spectra shown in Figures 1C, 1D, and S1A, samples were prepared as below. 22 
Erythrocytes (5 µl) were mixed with each chemical (PBS, 0.1 M NaOH, 25 wt% 23 
#10, or CUBIC-1 reagent), and incubated at 37°C overnight. The mixtures and 24 
supernatant from CUBIC-1- or #10-treated PFA-fixed blood were diluted 10-fold 25 
 2 
 
with each chemical. We also prepared 10 µM of hemin (Tokyo Chemical Industry, 1 
Japan), 10 µM of biliverdin (Sigma-aldrich), and 100µM of iron(II) chloride 2 
(Nacalai Tesque, Japan), solubilized with CUBIC-1 reagent or #10. The visible 3 
spectra of samples were recorded by UV/Vis spectrometer (JASCO, V-550, 4 
Japan). In Figure S1B, 50 g of CUBIC-1 reagent, 25 wt% aminoalcohol #10, 25 5 
wt% basic glycerol, 25 wt% basic urea, 15 wt% basic Triton X-100, or 0.01 M 6 
NaOH were titrated with 1 M HCl. pH was measured by pH meter (HORIBA, 7 
LAQUAtwin, Japan). In the decoloring capacity test shown in Figures 1E and 8 
S1C, the mixtures (200 µl) of erythrocytes and each chemical (CUBIC-1 reagent, 9 
25 wt% #10, 25 wt% glycerol containing 0.01 M NaOH, 25 wt% urea containing 10 
0.01 M NaOH, 15 wt% Triton X-100 containing 0.01 M NaOH, or 0.01 M NaOH) 11 
with different mixing ratio (eryhtocyte/chemical = 0.01 to 0.20) were incubated at 12 
37°C overnight. Bright-field images of these samples were captured. The OD575 13 
and OD600 values of the mixtures were measured with the PowerWave XS and 14 
the attached operation software (Bio-Tek). Since the absorbance was saturated 15 
at erythrocyte/chemical ratio = 0.20 in Figure 1E, the OD600/OD575 values at 16 
this ratio were not collected in Figure S1C. In the pH dependency of heme 17 
release by CUBIC-1 reagent, #10, tris(hydroxymethyl)aminomethane, or NaOH 18 
aqueous solution (Figure 1F), pHs of CUBIC-1 reagent and #10 solutions were 19 
adjusted by acidification with HCl. Erythrocytes (5 µl) were mixed with each 20 
chemical (CUBIC-1 reagent, 25 wt% #10, or NaOH solution), and incubated at 21 
37°C for 1h. The OD575 and OD600 values of the mixtures were measured with 22 
the PowerWave XS. Haupts U. et al. revealed that GFP fluorescence signals 23 
were more intensified in the moderate basic condition (pH 8-11) than in the 24 
neutral condition (pH 7.0) (Haupts et al., 1998). In our previous manuscript, we 25 
also demonstrated that GFP signals in some of 10 wt% basic aminoalcohols 26 
were higher than those in PBS (pH 7.4) (Susaki et al., 2014). Therefore, 27 
 3 
 
moderate basic condition between pH 8 to 11 was optimal for fluorescence 1 
proteins. Additionally, aminoalcohol #10 has a strong buffering ability around pH 2 
10 as shown in Figure S1B. Therefore, pHs in the medium could be kept 3 
between 10 to 11 through the CUBIC clearing protocol due to the daily exchange 4 
of the clearing medium. Actually, we showed the final pH values of the mixtures 5 
of erythrocyte and #10/CUBIC-1 were maintained over 10 as shown in the 6 
revised Figure 1E. Thus, we focused on the pH range between 9 to 13 in the 7 
experiment. In the blood-decoloring by a series of aminoalcohol-related 8 
chemicals shown in Figure S1D, the mixtures were prepared according to the 9 
experiment of Figure 1E. Initial pH value in each chemical was pre-adjusted so 10 
that final pH ranges from 10.8 to 11.2.  11 
 12 
Mice 13 
The β-actin-mKate2 knock-in mouse (β-actin-nuc-3xmKate2) strain was 14 
established in our laboratory. A back-bone vector for targeting, pTVCI3, 15 
harboring all of the required elements, including the thymidine kinase (TK) 16 
promoter-driven cDNA encoding Diphtheria Toxin A-fragment (DT-A) from 17 




GAAAGAACCAGCTGGGGCTCGATCCCTCGAGATCGGATATC-3') as a 22 
multiple cloning region, was constructed by inserting these sequences at the 23 
EcoRV site of self-concatenated pGEM-T-Easy (Promega) after removal of 24 
potential cutting sites for PI-PspI and PI-SceI from pGEM-T-Easy. The multiple 25 
 4 
 
cloning region of resulting pTVCI3 contains I-SceI, PI-SceI, I-CeuI, PI-PspI, XhoI 1 
and EcoRV site as single restriction site, respectively. The 3' homologous arm of 2 
β-actin was amplified from C57BL/6 mouse genomic DNA using PCR with the 3 
following primers: forward primer: (5’-CAGCTTGTGGCTCTGTGGCTTTGC-3’, 4 
Hokkaido System Science), reverse primer: 5 
(5’-ATGAAGAGATTGCTCAGTAGTTGAGAGAGTG-3’). PCR product was 6 
treated with Mighty Cloning kit (TaKaRa) for 5’-end phosphorylation, and cloned 7 
into the EcoRV site of pTVCI3, and the resulting vector was designated as 8 
pTVCI3-3arm. The 5' homologous arm of β-actin was amplified from C57BL/6 9 
mouse genomic DNA using PCR with the following primers: forward primer: 10 
(5’-AACACCTCCAGTTATTGGACCACTGG-3’), reverse primer: 11 
(5’-GTGCACTTTTATTGGTCTCAAGTCAGTG-3’). PCR product was treated 12 
with Mighty Cloning kit for 5’-end phosphorylation. pTVCI3-3arm was digested 13 
with I-SceI (New England BioLabs), and blunted with T4 DNA polymerase 14 
(TaKaRa). The 5' homologous arm fragment was ligated at the blunted I-SceI 15 
site of pTVCI3-3arm, and designated as pTVCI3-5arm-3arm. 16 
pTVCI3-5arm-3arm was digested with PI-SceI (New England BioLabs), blunted 17 
with T4 DNA polymerase. The Reading Frame Cassette B fragment from the 18 
Gateway Vector Conversion System (Life Technologies) was cloned into the 19 
blunted PI-SceI site of pTVCI3-5arm-3arm, and the resulting vector was 20 
designated as pTVCI3-β-actin-GW. pTVCI3-β-actin-GW was mixed with 21 
pENTR-1A_CAG-nuc-3×mKate2-WPRE-PuroR (Susaki et al., 2014) to perform 22 
the LR recombination reaction using the Gateway LR Clonase II Enzyme mix 23 
(Life Technologies). In the resulting targeting vector, the insertion cassette was 24 
in the same orientation as the β-actin gene. 25 





C-3', TALEN binding sequences are indicated with italics) containing a 3 
polyadenylation signal sequence were designed using TALE-NT (Doyle et al., 4 
2012). The targeting vector and TALEN-expression vector were purified and 5 
introduced into HK3i C57BL/6 mouse embryonic stem (ES) cells (Kiyonari et al., 6 
2010) using Xfect Transfection Reagent (Clontech Laboratories, Inc. A Takara 7 
Bio Company) according to the manufacturer's instructions, and the homologous 8 
recombined, puro-resistant ES cell clones were isolated for further culture and 9 
expansion. An aliquot of the cells was lysed and screened for successful 10 
homologous recombination by PCR. The integrity of the targeted region was 11 
confirmed by PCR using primers annealing outside the homologous 12 
recombination arms and within the inserted cassette. The primers used for the 13 
screening and the confirmation of genome integrity were as follows: 1) forward 14 
primer annealing to the region upstream of the 5' homologous arm: 15 
5’-CTGGCAGTCACCCAGAGACACTAGC-3’, 2) reverse primer annealing to the 16 
region downstream of the 5' homologous arm: 17 
5’-GTTAGTGCAGGCCAACTTGGCCTAGG-3’, 3) forward primer annealing to 18 
the region upstream of the 3' homologous arm: 19 
5’-AGGATGGTCGCGTCCATGCCCTGAG-3’, 4) reverse primer annealing to the 20 
region downstream of the 3' homologous arm: 21 
5’-ACTTCCAGGAGCCCTATGTGGTAGC-3’, 5) reverse primer annealing to the 22 
region between 5’ homologous arm and Gateway cassette of pTVCI3: 23 
5’-GGTAATGAAATGGGATCCTATATTACCC-3’, and 6) forward primer 24 
annealing to the region between 3’ homologous arm and Gateway cassette of 25 
pTVCI3: 5’-GAAAGAACCAGCTGGGGCTCGATCC-3’. The copy number of the 26 
inserted cassette was confirmed with a quantitative PCR assay using primers 27 
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annealing to the coding sequences of the puro-resistance gene (forward primer: 1 
5’-CTCGACATCGGCAAGGTGTG-3’, reverse primer: 2 
5’-GGCCTTCCATCTGTTGCTGC-3’) (Susaki et al., 2014), normalized to the 3 
amount of TATA-box binding protein gene amplification (forward primer: 4 
5’-CCCCCTCTGCACTGAAATCA-3’, reverse primer: 5 
5’-GTAGCAGCACAGAGCAAGCAA-3’) (Tsujino et al., 2013) using the SYBR 6 
Premix Ex Taq GC (Takara) and the ABI PRISM 7900 (Applied Biosystems). 7 
The selected ES cell clones were injected into 8-cell-stage ICR embryos to 8 
generate ~100% ES cell-derived chimeras (Kiyonari et al., 2010). 9 
We also used the R26-H2B-EGFP (CDB0238K) mouse strain (Abe et al., 2011), 10 
the Thy1-YFP-H transgenic mouse strain (Feng et al., 2000), the 11 
R26-pCAG-nuc-3xmKate2 mouse strain (Susaki et al., 2014), and the 12 
C57BL/6-Tg (CAG-EGFP) mouse strain (Okabe et al., 1997) to observe static 13 
fluorescent gene-expression patterns in whole-organ imaging. Mouse strains 14 
were maintained in the C57BL/6 background. We purchased the 15 
BALB/cAJcl-nu/nu mouse strain from CLEA Japan, Inc. and the C57BL/6-Tg 16 
(CAG-EGFP) mouse strain from Japan SLC, Inc. 17 
All experimental procedures and housing conditions were approved by the 18 
Animal Care and the Use Committee of Graduate School of Medicine, the 19 
University of Tokyo or by the Animal Care and Use Committee of the RIKEN 20 
Kobe Institute and all of the animals were cared for and treated humanely in 21 
accordance with the Institutional Guidelines for Experiments using animals. We 22 
fed DietGel Recovery (LSG Corporation, 72-06-5022, Japan) to mice for imaging 23 




Mouse Model of Streptozotocin (STZ)-induced Diabetes 1 
Diabetes was induced in male C57BL/6N mice at 8 weeks by a single 2 
intraperitoneal administration of saline (Otsuka Pharmaceutical Co., Ltd., 3 
14987035081514, Japan) or 10 mg/ml streptozotocin (total 200 mg/kg, Wako 4 
Pure Chemical Industries, Ltd., 197-15153, Japan) dissolved in saline at day 0. 5 
At day 0 and day 4, blood glucose values were measured by a blood glucose 6 
monitor (GLUCOCARD G Black; ARKRAY, Inc., Japan) after fasting for 6 hrs. 7 
Body weight was also measured at the same days. These data were 8 
summarized in Table S1. Mice with blood glucose levels over 300 mg/dl (n = 5) 9 
at day 4 and saline-administered mice (n = 4) were used for clearing with CUBIC 10 
(CB)-perfusion and PI staining. Imaging was performed using mice with the 11 
highest blood glucose levels (n = 3) of STZ group and corresponding number of 12 
control group (n = 3). 13 
 14 
Comparison of Clearing Methods 15 
For Figure 2A, we compared four chemical-based clearing methods. For 16 
collecting organ samples, adult mice (C57BL/6N and BALBc-nu/nu) were 17 
sacrificed by an overdose of pentobarbital (>100 mg/kg, Kyoritsu Seiyaku, 18 
Japan) and then perfused with 10 ml of 10 U/ml of heparin (Wako Pure Chemical 19 
Industries, Ltd., 081-00136, Japan) in PBS (pH 7.4) and 20 ml of 4% (w/v) 20 
paraformaldehyde (PFA, Nacalai Tesque Inc., 02890-45, Japan) in PBS via left 21 
ventricle of the heart. The excised organs (brain, heart, lung, right lobe of the 22 
liver, both side of the kidneys, pancreas, spleen, stomach, intestine, triceps 23 
surae muscle and skin) were post-fixed in 4% (w/v) PFA for 24 hr at 4°C. The 24 
specimens were washed with PBS for 20 min x three times to remove PFA just 25 
 8 
 
before clearing. 1 
Uncleared organs (negative control) were stocked in PBS with 0.01% Sodium 2 
Azide (Nacalai Tesque Inc., 31208-82, Japan) at 4°C after fixation. In SeeDB 3 
standard protocol (Ke et al., 2013), the fixed organs were serially rotated (4 rpm) 4 
in 30 ml of 20%, 40%, 60% (w/v) fructose (Nacalai Tesque Inc., 16315-55, 5 
Japan) for 8 hr each and in 30 ml of 80%, 100% (w/v) fructose for 12 hr each. 6 
From day 3, these organs were rotated in 30 ml of SeeDB (80.2% w/w fructose) 7 
at 25°C. SeeDB solution was replaced to the fresh one every day until 8 
observation. All fructose solutions contained 0.5% α-thioglycerol (Tokyo 9 
Chemical Industry CO. LTD., S0374, Japan). In Sca/eA2 and Sca/eB4 protocol 10 
(Hama et al., 2011), the fixed organs were immersed in 20% (w/v) sucrose 11 
(Nacalai Tesque Inc., 30403-55, Japan) at 4°C for 24 hr. These organs were 12 
embedded in OCT compound (Sakura Finetek Japan Co., Ltd., 4583, Japan) 13 
and frozen at -80°C. The next day, they were thawed in PBS and fixed again in 14 
4% PFA. From day 3, these organs were rotated in 30 ml of ScaleA2 (4 M urea, 15 
Nacalai Tesque Inc., 35904-45, Japan, 10% (w/v) glycerol, Nacalai Tesque Inc., 16 
17018-25, Japan and 0.1% (v/v) Triton X-100, Nacalai Tesque Inc., 25987-85, 17 
Japan) for 2 days, 30 ml of ScaleB4 (8 M urea, 0.1% (v/v) Triton X-100) for 2 18 
days, and 30 ml of ScaleA2 for 3 days in this order. All of the Scale solutions 19 
were replaced to the fresh one every day until observation. 20 
Two CUBIC reagents were prepared as previously reported (Susaki et al., 2014). 21 
Aminoalcohol #10 [N,N,N’,N’-Tetrakis(2-hydroxypropyl)ethylenediamine (Tokyo 22 
Chemical Industry CO., LTD., T0781, Japan)] is a constituent of previously 23 
published CUBIC-1 chemical cocktail. Aminoalcohol #16 [2,2’,2”-Nitrilotriethanol 24 
(Wako Pure Chemical Industries Ltd., 145-05605, Japan)] is a constituent of 25 
previously published CUBIC-2 chemical cocktail. In brief, ScaleCUBIC-1 26 
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(CUBIC-1 reagent) was prepared as a mixture of 25 wt% urea, 25 wt% 1 
aminoalcohol #10, and 15 wt% Triton X-100. Sca/eCUBIC-2 (CUBIC-2 reagent) 2 
was prepared as a mixture of 50 wt% sucrose, 25 wt% urea, 10 wt% 3 
aminoalcohol #16, and 0.1 % (v/v) Triton X-100. 4 
We adopted two CUBIC protocols for this comparing experiment. For 5 
preparation of CUBIC-treated (non-perfused) samples, the fixed organs (from 6 
C57BL/6N) and skin (BALBc-nu/nu, to save plucking hairs before clearing) were 7 
immersed in 30 ml of CUBIC-1 reagent at 37°C with gentle shaking for 5 days. 8 
These organs were then washed with PBS and immersed in 50% glycerol at 9 
room temperature on day 6. They were immersed in 30 ml of CUBIC-2 reagent 10 
at room temperature on day 7 and at 37°C after day 8. 11 
To make CUBIC-1 reagent penetrate throughout the whole body, we also 12 
performed the CUBIC (CB)-perfusion protocol as follows; the anesthetized 13 
mouse was perfused with 10 ml of 10 U/ml of heparin in PBS, 150 ml of 4% (w/v) 14 
PFA in PBS, 20 ml of PBS (to wash out PFA), and 20 ml of 50% (v/v) CUBIC-1 15 
reagent (1 : 1 mixture of water : CUBIC-1 reagent) in this order via left ventricle 16 
of the heart. The resulted organs were excised and continuously immersed in 30 17 
ml of CUBIC-1 reagent at 37°C with gentle shaking for 5 days. These organs 18 
were washed with PBS, immersed in 50% glycerol in PBS at room temperature 19 
on day 5. Then, they were immersed in 30 ml of CUBIC-2 reagent at room 20 
temperature on day 6 and at 37°C after day 7. 21 
In all four clearing methods, stomach and intestine were separately immersed 22 




Measurement of Light Transmittance 1 
For Figures S2A and S2B, we measured light transmittance of the brain, heart, 2 
lung, liver and kidney samples use in Figure 2A, from 380 to 780 nm at 5 nm 3 
intervals with an integrating sphere (Spectral Haze Meter SH 7000, Nippon 4 
Denshoku Industries Co., Ltd., Japan). We put every sample in the center of the 5 
optical cell (Nippon Denshoku Industries Co., Ltd., 2277, Japan) without liquid to 6 
avoid sample floating. Finally, the height of the sample and the aperture of 7 
integrating sphere were adjusted before measurement.  8 
In the instrument, two values can be determined: (1) diffused (scattered) light 9 
transmittance (%) which is the value for the light transmitted through the tissue, 10 
(2) parallel (non-diffused) light transmittance (%) which is the value for the light 11 
detected without any prevention. Diffused light transmittance was calculated as 12 
the value of (total light transmittance – parallel light transmittance) in the 13 
integrating sphere. We also calculated (100 – parallel light transmittance) as a 14 
tissue size-related value, because the sample makes a ‘shadow’ over the 15 
parallel light detector and the ‘shadow’ size is related to the sample size. Thus, 16 
the final transmittance was calculated by the diffused light transmittance divided 17 
by the value of (100 – parallel light transmittance) to be compensated with the 18 
tissue size and compared directly even between the values from different tissues. 19 
Finally, the final transmittance from four samples was averaged. 20 
 21 
The CUBIC Protocol for Whole Body and Organ Imaging 22 
For whole body and organ imaging, we slightly modified the above CUBIC 23 
protocol to improve the transparency and quality of imaging data (Figures 2B, 3, 24 
 11 
 
and 4). 1 
For whole body imaging, adult (6 – 19 weeks old) mouse were subjected to the 2 
same CB-perfusion protocol as above, and then the CB-perfused mouse was 3 
immersed in 200 ml of CUBIC-1 reagent at 37°C with gentle shaking for at least 4 
two weeks. To facilitate the whole-body clearing, the reagent was refreshed daily 5 
for two weeks. The clearing medium gradually became less colored, and after 6 
two weeks the apparent transparency of the whole body became saturated. 7 
Whole-body samples can be then stored in CUBIC-1 reagent, and even shaken 8 
in 37°C over months until observation because the high pH of CUBIC-1 reagents 9 
prevents proliferation of microorganisms. The resulted sample was used for 10 
imaging and thus we did not perform further clearing with CUBIC-2 reagent. 11 
For whole organ imaging, adult mice were subjected to the CB-perfusion 12 
protocol as above. Organs were excised and continuously immersed in 30 ml 13 
(stomach, intestine) or 60 ml (brain, heart, lung, liver, kidneys, pancreas, spleen, 14 
muscle) of CUBIC-1 reagent at 37°C with gentle shaking at least for 7 days. To 15 
facilitate the clearing, the reagent was refreshed daily for one week, and the 16 
transparency was saturated within 10 days as in Figure 2 and S2. The samples 17 
can be then stored in CUBIC-1 reagent, and even shaken in 37°C over weeks to 18 
months to prevent proliferation of microorganisms as above. These organs were 19 
washed with PBS, immersed in 50% glycerol in PBS at room temperature, and 20 
then they were immersed in 30 ml of CUBIC-2 reagent for each group at room 21 
temperature on the first day and at 37°C after the second day. Images were 22 
acquired after 3 days~ incubation in CUBIC-2 reagent. 23 
For skin imaging in Figure 4E, a CAG-EGFP Tg mouse (10-week-old) was also 24 
subjected to CB-perfusion as above. The excised skin and ear were needed to 25 
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remove subcutaneous tissues and hairs, and thus we washed the specimens 1 
with PBS several times and then post-fixed and cleared according to 2 
non-perfusion protocol as above 10-day protocol. Images were acquired on day 3 
12. 4 
For a neonatal (postnatal day 1 or day 6) mouse clearing, 3 ml of 10 U/ml of 5 
heparin in PBS, 10 ml of 4% (w/v) PFA in PBS, 3 ml of PBS and 5 ml of 50% 6 
(v/v) CUBIC-1 reagent were perfused in this order via left ventricle of the heart 7 
after the anesthetization. Furthermore, 3 ml of CUBIC-1 reagent were 8 
additionally perfused for improving the transparency. Gastrointestinal tract was 9 
also flushed with CUBIC-1 reagent from the mouth. The mouse was then 10 
immersed in 30 ml of CUBIC-1 reagent at 37°C with gentle shaking for at least 2 11 
weeks. To facilitate the clearing, the reagent was refreshed daily for two weeks. 12 
The samples can be then stored in CUBIC-1 reagent, and even shaken in 37°C 13 
over weeks to months to prevent proliferation of microorganisms as above. This 14 
sample was used for imaging and thus we did not perform further clearing with 15 
CUBIC-2 reagent. 16 
Whole body and organs were stained with nucleic acid stain (propidium iodide 17 
(PI), life technologies, P21493 or SYTO 16, life technologies, S7578), added in 18 
50% (v/v) CUBIC-1 reagent (for CB-perfusion), CUBIC-1 and -2 reagents (during 19 
clearing) at a concentration of 10 µg/ml PI or 0.5 µM SYTO16, when indicated. 20 
Note that 50% (w/v) Glycerol in PBS used before CUBIC-2 reagent can be 21 
exchanged with 20% (w/v) sucrose in PBS in the original brain clearing protocol 22 





Whole-body and organ fluorescence images were acquired with light-sheet 2 
fluorescence microscopy (LSFM) (Ultramicroscope, LaVision BioTec, Germany) 3 
as reported previously (Dodt et al., 2007; Susaki et al., 2014). Samples were 4 
immersed in a 1:1 mixture of silicon oil TSF4300 (Momentive Performance 5 
Materials Inc., RI = 1.498) and mineral oil (Sigma-Aldrich, RI = 1.467), and were 6 
put on a glass plate held with a customized sample holder. Images were 7 
captured at 0.63× to 5× zoom with the MVX-ZB10. Each plane was illuminated 8 
from both the right and left sides, and a merged image was saved. The exposure 9 
times were adjusted according to the fluorescent signal intensities of each 10 
sample. 11 
 12 
Image Data Processing and Analysis 13 
All raw image data were collected in a lossless 16-bit TIFF format. 3D-rendered 14 
images were visualized and captured with Imaris software (version 7.6.4 and 15 
7.7.1, Bitplane). Brightness, contrast, and gamma of the 3D-rendered images 16 
were manually adjusted with the software at minimum when visualized.  17 
We performed blind 3D deconvolution for a set of our LSFM Z-stack images with 18 
software AutoQuant X3 (Media Cybernetics). Because the software does not 19 
have a preset for a macrozoom LSFM images, we searched parameters to 20 
significantly improve the raw tiff images. Using the expert settings, we performed 21 
the 3D blind deconvolution with 50 iterations, noise manually set to 0, and the 22 
original unfiltered image as initial guess. Montage was used both in the XY and Z 23 
directions, with 15-pixel sub-volume overlap. RIs were to 1.00 and 1.49, with 24 
 14 
 
lens aperture at 0.15. Spacing, wavelength and magnitude settings are 1 
sample-dependent, and all other parameters were kept to the default values for 2 
the "multi-photon fluorescence" modality. Results were saved as 16-bit tiff 3 
images. 4 
The reconstituted 3D images were then used for image analysis with Imaris 5 
software (Bitplane). For the visualization of anatomical structures (Figures 6, S7, 6 
and S8), we selected appropriate analytical segments in each organ and 7 
manually extracted signal intensities correlated with these structures on the 8 
Surface analysis of the software. Then, each structure was manually curated 9 
and extra Surface signals were eliminated. 10 
For extraction, counting, and volume calculation of pancreatic islets, pancreases 11 
derived from the STZ experiment and cleared by CB-Perfusion with PI staining 12 
were used. Whole-tissue 3D images of each pancreas were acquired as 6 to 13 
10-divided region images with 4× zoom of MVX10. The merged areas were 14 
annotated manually. Each islet was morphologically detected in the entire X-Y 15 
plane images. Then, a 3D region including one to three islets was selected for 16 
Surface analysis of Imaris software. The size of automatically selected Surface 17 
was manually adjusted to the actual islet size by changing Threshold (Absolute 18 
intensity) parameter. To remove Surfaces other than islet, Volume parameter 19 
was changed to 103 or 104 voxel number (depending on the islet size of the 20 
selected region), and manually removed the remaining Surfaces other than islet. 21 
Number and volume of islets were calculated by Imaris. Further statistical 22 
analyses between saline- or STZ- administered groups were performed using R 23 
software (Kolmogorov-Smirnov test for difference in islet size distribution, and 24 
comparison of total islets, islets larger or smaller than 1.0 × 107 µm3 for t-test). 25 
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As a pilot study, we considered the automatic extraction of relevant anatomical 1 
structures in the heart and pancreas. For heart samples, analysis is performed in 2 
Fiji (Schindelin et al., 2012). We successively run the “Smooth” and “Find Edges” 3 
methods, followed by the “Tubeness” plugin (with sigma=1). Finally, we apply a 4 
binary mask to keep only pixels with intensity higher than 400. As shown in 5 
Figure S7B, the method successfully extracts coronary arteries and most of 6 
them were merged to the manual extracted Surface signal in Imaris. For the 7 
pancreas samples, the objective is to accelerate the identification of Langerhans 8 
islets. Our method relies on two properties of these islets: (a) even though their 9 
intensity varies, the islets are generally brighter than their immediate 10 
surroundings; (b) islets have a roughly spherical shape. The first property is 11 
used in the pre-processing method, implemented in C++. Using a sliding window, 12 
we measure the average intensity in each region of each Z-slice of the 3D image, 13 
and only keep pixels with intensity at least 10% higher than this local average. 14 
All other pixels are set to 0. Each pre-processed 2D slice is then analyzed in Fiji. 15 
We run the “Find Edges” method, followed by computing of the largest absolute 16 
eigenvalue of the Hessian matrix (using the corresponding FeatureJ plugin with 17 
smoothing = 1), to identify clusters that do not have the desired shape. At each 18 
pixel, the eigenvalue is then multiplied by seven and subtracted from the current 19 
intensity. We save the resulting file for each slice, and re-construct the 3D image. 20 
While the method still needs to be refined, early results on the clearest slices are 21 
encouraging (Figure 5C). For darker slices, curation of the result file removes 22 
inaccurate annotations. This process will be automatized in future versions. 23 
 24 
3D Immunostaining of CUBIC Samples 25 
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3D IHC protocol for CUBIC samples was according to our previous paper 1 
(Susaki et al., 2014). Organ samples with CB-Perfusion were treated with 2 
CUBIC-1 for 7 days, washed with PBS, immersed in 20% (w/v) sucrose in PBS, 3 
and frozen in O.C.T. compound at –80°C overnight. The frozen samples were 4 
then thawed, washed with PBS, and subjected to immunostaining with the 1:100 5 
diluted fluorescent-labeled antibodies in 5 ml of 2% (v/v) Triton X-100 in PBS for 6 
3 days at 4°C with rotation. The stained samples were then washed with 5 ml of 7 
PBS several times at 37°C with rotation. The stained samples were then 8 
immersed in CUBIC-2 for 4 to 15 hrs. The following antibodies were used for the 9 
staining: Cy3-conjugated anti-α-smooth muscle actin (α-SMA) antibody 10 
produced in mouse (Sigma, C6198) for heart, kidney, stomach, and intestine, 11 
and monoclonal FITC-conjugated anti-Pan cytokeratin antibody [C-11] (abcam, 12 
ab78478) for lung. These antibodies were mixed with the samples after filtration 13 





SUPPLEMENTAL FIGURE LEGENDS 2 
Figure S1. Aminoalcohols in CUBIC Cocktails Decolorized the Blood by 3 
Efficiently Eluting Heme Chromophore, Related to Figure 1 4 
(A) Normalized visible spectra of 0.1% mouse erythrocyte (black), 1/10 diluted 5 
supernatant from Figure 1A (red), 10 µM hemin (blue), 10 µM biliveridin 6 
(orange), and 100 µM iron(II) chloride (green), in CUBIC-1 reagent. (B) 50 g of 7 
CUBIC-1 reagent (red circle, n = 3), 25 wt% aminoalcohol #10 (magenta square, 8 
n = 3), 25 wt% basic glycerol (blue triangle, n = 3), 25 wt% basic urea (green 9 
cross, n = 3), 15 wt% basic Triton X-100 (orange bar, n = 3), or 0.01 M NaOH 10 
(black diamond, n = 3) were titrated with 1 M HCl. pHs are plotted against the 11 
titrated volume of 1 M HCl. Data represent the average ± SD. (C) OD600/575 12 
values of 1% to 20% erythrocyte solution mixed with CUBIC-1 reagent (red circle, 13 
n = 3), 25 wt% aminoalcohol #10 (magenta square, n = 3), 25 wt% basic glycerol 14 
(blue triangle, n = 3), 25 wt% basic urea (green cross, n = 3), 15 wt% basic Triton 15 
X-100 (orange bar, n = 3), and 0.01 M NaOH (black diamond, n = 3) in Figure 16 
1E are plotted against erythrocyte/chemical mixture ratio. Data represent the 17 
average ± SD. (D) OD600/575 values of 1% erythrocyte solution mixed with a 18 
series of aminoalcohols [primary amine (green, n = 3), secondary amine (orange, 19 
n = 3), tertiary amine (magenta, n = 3), or amine bearing carboxylic acid (purple, 20 
n = 3)], NaOH (black, n = 3), basic glycerol (blue, n = 3) or CUBIC-1 reagent (red, 21 
n = 3) is shown. Initial pH value in each chemical was pre-adjusted so that final 22 
pH ranges from 10.8 to 11.2. Data represent the average ± SD. (E) Chemical 23 
structures of glycerol and a series of aminoalcohols examined in this study. 24 
Numbering of the chemicals was derived from the previous chemical screening. 25 
Glycerol is a polyhydric alcohol without an amine group. 26 
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3-Amino-1,2-propanediol (#8), 2-amino-1,3-propanediol (#15), and 1 
tris(hydroxymethyl)aminomethane (Tris) are aminoalcohols with primary amine. 2 
3-Methylamino-1,2-propanediol (#4) is a aminoalcohol with a secondary amine 3 
group. N,N,N',N'-Tetrakis(2-hydroxyethyl)ethylenediamine (#9), 4 
N,N,N',N'-tetrakis(2-hydroxypropyl)ethylenediamine (#10), triethanolamine (#16), 5 
and triisopropanolamine (#17) are aminoalcohols with a tertiary amine group. 6 
Dihydroxyethyl glycine (DHEG) and ethylenediaminetetraacetic acid (EDTA) are 7 





Figure S2. CUBIC Is a Simple and Efficient Whole-organ and Whole-body 2 
Clearing Protocol, Related to Figure 2 3 
(A) Temporal development of transmittance of different organs (brain, heart, 4 
lung, kidney, and liver) with each protocol. Average light transmittance of fixed 5 
whole organs treated with PBS (black, n = 4), the Scale protocol (green, n = 4), 6 
the SeeDB protocol (blue, n = 4), the CUBIC protocol (pink, n = 4) or the 7 
CB-Perfusion protocol (red, n = 4), were measured. Data represent the average 8 
± SD. (B) Transmission curves of different organs (brain, heart, lung, kidney, and 9 
liver) with each protocol after 10 days. Light transmittance around the visible 10 
region (380-780 nm) of fixed whole organs treated with PBS (black, n = 4), Scale 11 
protocol (green, n = 4), SeeDB protocol (blue, n = 4), CUBIC protocol (pink, n = 12 
4) or the CB-Perfusion protocol (red, n = 4) were measured. Data represent the 13 
average ± SD. (C) Bright-field images (dorsal view) of fixed whole body 14 
(C57BL/6N adult mice) stocked in PBS or subjected to the CB-Perfusion 15 
protocol, also shown in Figure 2B. 8-week-old mouse for the PBS sample and 16 





Figure S3. CUBIC Is Applicable to Whole-body Imaging of Infant and Adult Mice 2 
with Single-cell Resolution, Related to Figure 3 3 
(A) 3D-reconstituted and X-Y plane body images of PI-stained CAG-EGFP Tg 4 
P1 mouse. Chest organs (D-V) are shown. The image was deconvolved with 5 
AutoQuant X3 software. Z-stack: 20-µm step, with 4.0 seconds × two 6 
illuminations for EGFP and with 0.1 to 0.15 seconds × two illuminations for PI. 7 
Zoom of the microscope: 2.0×. Prefix “DCV-” indicates the deconvolved image. 8 
(B) 3D-reconstituted and X-Y plane body images of the PI-stained CAG-EGFP 9 
Tg adult mouse (8-week-old). Forelimb is shown. Z-stack: 20-µm step, with 0.4 10 
to 2.0 seconds × two illuminations for EGFP and with 0.1 to 0.2 seconds × two 11 
illuminations for PI. Zoom of the microscope: 0.8×. (C) 3D-reconstituted and X-Y 12 
plane (indicated with Z position) body images of the PI-stained CAG-EGFP Tg 13 
P6 mouse. Head (D-V), chest organs (V-D and D-V), abdominal and pelvic 14 
organs (V-D and D-V) are shown. Z-stack: 20-µm step, with 4.0 seconds × two 15 
illuminations for EGFP and with 0.1 seconds × two illuminations for PI. Zoom of 16 





Figure S4. Magnified Organ Images of CAG-EGFP Tg P1 Mouse, Related to 2 
Figure 3 3 
3D-reconstituted magnified organ images (submaxillary gland, heart, lung, 4 
stomach, liver, kidney, intestine, spinal cord, scrotum, and leg) of the PI-stained 5 
CAG-EGFP Tg P1 mouse were acquired with LSFM. All images were 6 
deconvolved with AutoQuant X3 software. Z-stack: 20-µm step, with 4.0 seconds 7 
× two illuminations for EGFP and with 0.1 to 0.2 seconds × two illuminations for 8 
PI. Zoom of the microscope: 5.0×. Note that the structures inside the spiral canal 9 
or leg bones were detected (panels of spinal cord and leg). Prefix “DCV-” 10 





Figure S5. CUBIC Is Applicable to Whole-organ Imaging with Single-cell 2 
Resolution, Related to Figure 4 3 
(A - F) The reconstituted 3D and section images of the SYTO 16-stained mouse 4 
pancreas (A), spleen (B), soleus muscle (C), stomach (D), intestine (E), brain, 5 
another kidney (contralateral to the kidney shown in Figure 4C), and another 6 
soleus muscle (contralateral to the soleus muscle shown in Figure S5C) (F), of 7 
β-actin-nuc-3×mKate2 KI mouse (8-week-old) were acquired with LSFM. In A-E, 8 
images were deconvolved with AutoQuant X3 software. Raw X-Y section images, 9 
and reconstituted Y-Z and X-Z section images are at the indicated positions. (A) 10 
Pancreas images. Z-stack: 20-µm step × 321 planes, with 0.05 seconds × two 11 
illuminations for SYTO 16 and with 0.5 seconds × two illuminations for mKate2. 12 
Zoom of the microscope: 1.25×. (B) Spleen images. Z-stack: 20-µm step × 231 13 
planes, with 0.05 seconds × two illuminations for SYTO 16 and with 1.0 seconds 14 
× two illuminations for mKate2. Zoom of the microscope: 1.6×. (C) Soleus 15 
muscle images. Z-stack: 20-µm step × 331 planes, with 0.10 seconds × two 16 
illuminations for SYTO 16 and with 2.0 seconds × two illuminations for mKate2. 17 
Zoom of the microscope: 1.6×. (D) Stomach images. Z-stack: 20-µm step × 396 18 
planes, with 0.05 seconds × two illuminations for SYTO 16 and with 1.0 seconds 19 
× two illuminations for mKate2. Zoom of the microscope: 1.25×. (E) Intestine 20 
images. Z-stack: 20-µm step × 366 planes, with 0.05 seconds × two illuminations 21 
for SYTO 16 and with 2.0 seconds × two illuminations for mKate2. Zoom of the 22 
microscope: 1.0×. (F) The reconstituted 3D images of brain, contralateral kidney, 23 
and contralateral muscle. Zoom of the microscope: 1.25× for brain, 2.0× for 24 





Figure S6. CUBIC Is Applicable to the Whole-Organ Imaging of Various 2 
Fluorescent Proteins, Related to Figure 4  3 
(A) The reconstituted 3D whole-organ and magnified section images of heart, 4 
lung, kidney, pancreas, and intestine from CAG-EGFP Tg mouse (8-week-old) 5 
were acquired with LSFM. The magnified section images of EGFP/PI merged 6 
signals at the approximate 1 mm depth of each organ. Z-stack: 20-µm step, with 7 
0.3 to 2.0 seconds × two illuminations for EGFP and with 0.1 to 0.4 seconds × 8 
two illuminations for PI. Zoom of the microscope: 0.8× for intestine, 1.0× for 9 
pancreas, 1.25× for lung, 1.6× for heart and kidney, and 5.0× for all magnified 10 
section images. (B) The reconstituted 3D whole-organ images of lung, kidney, 11 
liver, and pancreas from R26-H2B-EGFP KI mouse (4-month old) were acquired 12 
with LSFM. Z-stack: 20-µm step, with 2.0 seconds × two illuminations for EGFP 13 
and with 0.1 to 0.3 seconds × two illuminations for PI. Zoom of the microscope: 14 
1.0× for pancreas, 1.25× for lung, liver, and kidney. (C) The reconstituted 3D 15 
whole-organ images of spleen and intestine from Thy1-YFP-H Tg mouse 16 
(8-week-old) were acquired with LSFM. Z-stack: 20-µm step, with 0.7 to 2.0 17 
seconds × two illuminations for YFP and with 0.1 to 0.3 seconds × two 18 
illuminations for PI. Zoom of the microscope: 0.8× for intestine and 1.25× for 19 






Figure S7. CUBIC Is Applicable to the 3D Anatomy of Organs, Related to 2 
Figure 6 3 
Manual extraction of internal structures was performed with Surface analysis of 4 
Imaris software. The reconstituted 3D images of the heart from the SYTO 5 
16-stained β-actin-nuc-3×mKate2 KI mouse (8-week-old) in Figure 4 were used. 6 
After Surface extraction by the software, each structure was manually curated 7 
and extra Surface signals were eliminated. (A) Detailed views of heart valves 8 
and surrounding structures. Cross sectional mKate2 images and surrounding 9 
structures (Surface volume, 3D) are shown. (B) Automatic identification of 10 
coronary vessels. Left panel: automated extraction of coronary vessels with 11 
Fiji-based pipeline. Right panel: manual extraction of coronary vessels with 12 
Imaris in Figure 6A (view from different direction). Extracted vessels with these 13 





Figure S8. CUBIC Is Applicable to the 3D Anatomy of Infant Body, Related to 2 
Figure 6 3 
Extraction of internal structures was performed with surface analysis of Imaris 4 
software, similar in Figure 6. The reconstituted 3D images of the chest (A), lung 5 
(B), liver (C), intestine (D), and esophagus and stomach (E) from the PI-stained 6 
CAG-EGFP Tg P1 mouse in Figure 3B were used. After surface extraction by 7 
the software, each structure was manually curated and extra surface signals 8 
were eliminated. (A) Overview of organ identification using the chest 3D image 9 
with single-cell resolution. Prefix “DCV-” indicates the deconvolved image. (B – 10 
E) Extraction and visualization of the bronchial tree (yellow) with organ surface 11 
(light blue) of lung in (B), vascular structure (olive) with organ surface (green) of 12 
liver in (C), intestinal wall (purple) and villi (peachpuff) in (D) and stomach 13 





Table S1. Blood Glucose Levels and Weight of Control and STZ Diabetic Mice, 2 
Related to Figure 5 3 
Plasma glucose levels (mg/dl) and weights (g) of WT C57BL/6N mice were 4 
determined before and four days after the intraperitoneal administration of saline 5 
(n = 4) or 200 mg/kg straptozotocin (STZ, n = 14). We diagnosed the onset of 6 
diabetes by the elevation over 300 mg/dl of blood glucose levels. In this 7 
experiment, 36% of STZ-treated mice as shown in red and blue developed acute 8 
type I diabetes. Three pancreases from each treatment (red) were cleared by the 9 
CB-Perfusion protocol with PI-staining. We performed whole-organ imaging of 10 
those pancreases by LSFM, and statistically analyzed by the Imaris software as 11 






Supplemental movie S1 2 
Reconstituted 3D images and Surface analysis data of the 3 
β-actin-nuc-3×mKate2 knock-in mouse heart (deconvolved), corresponding to 4 
Figure 6A. 5 
 6 
Supplemental movie S2 7 
Reconstituted 3D images and Surface analysis data of the 8 
β-actin-CAG-nuc-3×mKate2 knock-in mouse lung (deconvolved), corresponding 9 
to Figure 6B. 10 
 11 
Supplemental movie S3 12 
Surface analysis data of the β-actin-CAG-nuc-3×mKate2 knock-in mouse 13 
bronchial tree (light blue) and peripheral alveoli (green) in the lung 14 
(deconvolved), corresponding to Figure 6B. 15 
 16 
Supplemental movie S4 17 
Reconstituted 3D images and Surface analysis data of the 18 
β-actin-CAG-nuc-3×mKate2 knock-in mouse kidney (deconvolved), 19 




Supplemental movie S5 1 
Reconstituted 3D images and Surface analysis data of the 2 
β-actin-CAG-nuc-3×mKate2 knock-in mouse liver (deconvolved), corresponding 3 
to Figure 6D. 4 
 5 
Supplemental movie S6 6 
Reconstituted 3D images and Surface analysis data of the CAG EGFP Tg P1 7 
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